NAME	ORIGINAL SIZE	AFTER RESTRICTING TO DATASET	STATUS	
GLUTATHIONE METABOLISM%WIKIPATHWAYS_20250310%WP100%HOMO SAPIENS	19	18		
ALANINE AND ASPARTATE METABOLISM%WIKIPATHWAYS_20250310%WP106%HOMO SAPIENS	12	11		
TRANSLATION FACTORS%WIKIPATHWAYS_20250310%WP107%HOMO SAPIENS	52	51		
ELECTRON TRANSPORT CHAIN OXPHOS SYSTEM IN MITOCHONDRIA%WIKIPATHWAYS_20250310%WP111%HOMO SAPIENS	105	104		
GPCRS OTHER%WIKIPATHWAYS_20250310%WP117%HOMO SAPIENS	96	48		
OSTEOCLAST SIGNALING%WIKIPATHWAYS_20250310%WP12%HOMO SAPIENS	16	14		
IL5 SIGNALING%WIKIPATHWAYS_20250310%WP127%HOMO SAPIENS	37	35		
MATRIX METALLOPROTEINASES%WIKIPATHWAYS_20250310%WP129%HOMO SAPIENS	30	19		
PENTOSE PHOSPHATE METABOLISM%WIKIPATHWAYS_20250310%WP134%HOMO SAPIENS	7	7		
PHASE I BIOTRANSFORMATIONS NON P450%WIKIPATHWAYS_20250310%WP136%HOMO SAPIENS	8	6		
ANDROGEN RECEPTOR SIGNALING%WIKIPATHWAYS_20250310%WP138%HOMO SAPIENS	87	85		
AMP ACTIVATED PROTEIN KINASE SIGNALING%WIKIPATHWAYS_20250310%WP1403%HOMO SAPIENS	67	63		
SPHINGOLIPID PATHWAY%WIKIPATHWAYS_20250310%WP1422%HOMO SAPIENS	30	28		
GANGLIO SPHINGOLIPID METABOLISM%WIKIPATHWAYS_20250310%WP1423%HOMO SAPIENS	13	10		
BONE MORPHOGENIC PROTEIN SIGNALING AND REGULATION%WIKIPATHWAYS_20250310%WP1425%HOMO SAPIENS	12	11		
FATTY ACID BETA OXIDATION%WIKIPATHWAYS_20250310%WP143%HOMO SAPIENS	34	32		
NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN NOD PATHWAY%WIKIPATHWAYS_20250310%WP1433%HOMO SAPIENS	41	36		
OSTEOPONTIN SIGNALING%WIKIPATHWAYS_20250310%WP1434%HOMO SAPIENS	13	13		
INFLUENZA A VIRUS INFECTION%WIKIPATHWAYS_20250310%WP1438%HOMO SAPIENS	1		Rejected!	
SEROTONIN TRANSPORTER ACTIVITY%WIKIPATHWAYS_20250310%WP1455%HOMO SAPIENS	11	10		
TARGET OF RAPAMYCIN SIGNALING%WIKIPATHWAYS_20250310%WP1471%HOMO SAPIENS	36	36		
GLYCINE METABOLISM%WIKIPATHWAYS_20250310%WP1495%HOMO SAPIENS	3		Rejected!	
SELENIUM MICRONUTRIENT NETWORK%WIKIPATHWAYS_20250310%WP15%HOMO SAPIENS	87	70		
PHYSIOLOGICAL AND PATHOLOGICAL HYPERTROPHY OF THE HEART%WIKIPATHWAYS_20250310%WP1528%HOMO SAPIENS	24	23		
MIRNA REGULATION OF DNA DAMAGE RESPONSE%WIKIPATHWAYS_20250310%WP1530%HOMO SAPIENS	73	66		
VITAMIN D METABOLISM%WIKIPATHWAYS_20250310%WP1531%HOMO SAPIENS	10	9		
VITAMIN B12 METABOLISM%WIKIPATHWAYS_20250310%WP1533%HOMO SAPIENS	55	41		
ANGIOGENESIS%WIKIPATHWAYS_20250310%WP1539%HOMO SAPIENS	24	24		
ENERGY METABOLISM%WIKIPATHWAYS_20250310%WP1541%HOMO SAPIENS	48	47		
MICRORNAS IN CARDIOMYOCYTE HYPERTROPHY%WIKIPATHWAYS_20250310%WP1544%HOMO SAPIENS	104	78		
MIRNAS INVOLVED IN DNA DAMAGE RESPONSE%WIKIPATHWAYS_20250310%WP1545%HOMO SAPIENS	68	20		
TRANSCRIPTION FACTORS REGULATE MIRNAS RELATED TO CARDIAC HYPERTROPHY%WIKIPATHWAYS_20250310%WP1559%HOMO SAPIENS	9	8		
TYPE II DIABETES MELLITUS%WIKIPATHWAYS_20250310%WP1584%HOMO SAPIENS	21	18		
FOLATE ALCOHOL AND CANCER PATHWAY HYPOTHESES%WIKIPATHWAYS_20250310%WP1589%HOMO SAPIENS	10	10		
HEART DEVELOPMENT%WIKIPATHWAYS_20250310%WP1591%HOMO SAPIENS	47	32		
NICOTINE METABOLISM IN LIVER CELLS%WIKIPATHWAYS_20250310%WP1600%HOMO SAPIENS	6	5		
FLUOROPYRIMIDINE ACTIVITY%WIKIPATHWAYS_20250310%WP1601%HOMO SAPIENS	34	33		
NICOTINE EFFECT ON DOPAMINERGIC NEURONS%WIKIPATHWAYS_20250310%WP1602%HOMO SAPIENS	21	13		
NICOTINE EFFECT ON CHROMAFFIN CELLS%WIKIPATHWAYS_20250310%WP1603%HOMO SAPIENS	5		Rejected!	
CODEINE AND MORPHINE METABOLISM%WIKIPATHWAYS_20250310%WP1604%HOMO SAPIENS	14	12		
EICOSANOID SYNTHESIS%WIKIPATHWAYS_20250310%WP167%HOMO SAPIENS	23	20		
NUCLEAR RECEPTORS%WIKIPATHWAYS_20250310%WP170%HOMO SAPIENS	38	33		
TP53 NETWORK%WIKIPATHWAYS_20250310%WP1742%HOMO SAPIENS	19	17		
FOLATE METABOLISM%WIKIPATHWAYS_20250310%WP176%HOMO SAPIENS	70	54		
APOPTOSIS MODULATION AND SIGNALING%WIKIPATHWAYS_20250310%WP1772%HOMO SAPIENS	92	86		
CELL CYCLE%WIKIPATHWAYS_20250310%WP179%HOMO SAPIENS	120	114		
PROTEASOME DEGRADATION%WIKIPATHWAYS_20250310%WP183%HOMO SAPIENS	62	60		
INTEGRIN MEDIATED CELL ADHESION%WIKIPATHWAYS_20250310%WP185%HOMO SAPIENS	102	95		
HOMOLOGOUS RECOMBINATION%WIKIPATHWAYS_20250310%WP186%HOMO SAPIENS	13	13		
PEROXISOMAL BETA OXIDATION OF TETRACOSANOYL COA%WIKIPATHWAYS_20250310%WP1941%HOMO SAPIENS	4		Rejected!	
CORI CYCLE%WIKIPATHWAYS_20250310%WP1946%HOMO SAPIENS	17	15		
IL1 SIGNALING%WIKIPATHWAYS_20250310%WP195%HOMO SAPIENS	54	53		
CHOLESTEROL BIOSYNTHESIS PATHWAY%WIKIPATHWAYS_20250310%WP197%HOMO SAPIENS	15	15		
INTEGRATED CANCER PATHWAY%WIKIPATHWAYS_20250310%WP1971%HOMO SAPIENS	45	43		
THYROXINE THYROID HORMONE PRODUCTION%WIKIPATHWAYS_20250310%WP1981%HOMO SAPIENS	25	20		
STEROL REGULATORY ELEMENT BINDING PROTEINS SREBP SIGNALING%WIKIPATHWAYS_20250310%WP1982%HOMO SAPIENS	69	66		
INTEGRATED BREAST CANCER PATHWAY%WIKIPATHWAYS_20250310%WP1984%HOMO SAPIENS	153	146		
SRF AND MIRS IN SMOOTH MUSCLE DIFFERENTIATION AND PROLIFERATION%WIKIPATHWAYS_20250310%WP1991%HOMO SAPIENS	12	11		
GENES TARGETED BY MIRNAS IN ADIPOCYTES%WIKIPATHWAYS_20250310%WP1992%HOMO SAPIENS	13	11		
EFFECTS OF NITRIC OXIDE%WIKIPATHWAYS_20250310%WP1995%HOMO SAPIENS	8	6		
MIR TARGETED GENES IN ADIPOCYTES%WIKIPATHWAYS_20250310%WP2001%HOMO SAPIENS	19	17		
MIR TARGETED GENES IN LEUKOCYTES%WIKIPATHWAYS_20250310%WP2003%HOMO SAPIENS	127	123		
MIR TARGETED GENES IN LYMPHOCYTES%WIKIPATHWAYS_20250310%WP2004%HOMO SAPIENS	424	403		
MIR TARGETED GENES IN MUSCLE CELL%WIKIPATHWAYS_20250310%WP2005%HOMO SAPIENS	353	328		
MIR TARGETED GENES IN SQUAMOUS CELL%WIKIPATHWAYS_20250310%WP2006%HOMO SAPIENS	129	122		
IRON METABOLISM IN PLACENTA%WIKIPATHWAYS_20250310%WP2007%HOMO SAPIENS	11	8		
SREBF AND MIR33 IN CHOLESTEROL AND LIPID HOMEOSTASIS%WIKIPATHWAYS_20250310%WP2011%HOMO SAPIENS	16	16		
RANKL RANK SIGNALING%WIKIPATHWAYS_20250310%WP2018%HOMO SAPIENS	50	49		
CELL DIFFERENTIATION EXPANDED INDEX%WIKIPATHWAYS_20250310%WP2023%HOMO SAPIENS	59	15		
CELL DIFFERENTIATION INDEX%WIKIPATHWAYS_20250310%WP2029%HOMO SAPIENS	21	5		
THYROID STIMULATING HORMONE TSH SIGNALING%WIKIPATHWAYS_20250310%WP2032%HOMO SAPIENS	58	55		
LEPTIN SIGNALING%WIKIPATHWAYS_20250310%WP2034%HOMO SAPIENS	71	70		
FOLLICLE STIMULATING HORMONE FSH SIGNALING%WIKIPATHWAYS_20250310%WP2035%HOMO SAPIENS	24	20		
TNF RELATED WEAK INDUCER OF APOPTOSIS TWEAK SIGNALING%WIKIPATHWAYS_20250310%WP2036%HOMO SAPIENS	38	38		
PROLACTIN SIGNALING%WIKIPATHWAYS_20250310%WP2037%HOMO SAPIENS	74	73		
MICROTUBULE CYTOSKELETON REGULATION%WIKIPATHWAYS_20250310%WP2038%HOMO SAPIENS	48	45		
IL7 SIGNALING%WIKIPATHWAYS_20250310%WP205%HOMO SAPIENS	20	20		
ALZHEIMER 39 S DISEASE AND MIRNA EFFECTS%WIKIPATHWAYS_20250310%WP2059%HOMO SAPIENS	269	231		
FATTY ACID OMEGA OXIDATION%WIKIPATHWAYS_20250310%WP206%HOMO SAPIENS	15	10		
NEURAL CREST DIFFERENTIATION%WIKIPATHWAYS_20250310%WP2064%HOMO SAPIENS	101	68		
IL17 SIGNALING%WIKIPATHWAYS_20250310%WP2112%HOMO SAPIENS	32	27		
TYPE III INTERFERON SIGNALING%WIKIPATHWAYS_20250310%WP2113%HOMO SAPIENS	10	7		
ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY%WIKIPATHWAYS_20250310%WP2118%HOMO SAPIENS	75	60		
ENDOTHELIN PATHWAYS%WIKIPATHWAYS_20250310%WP2197%HOMO SAPIENS	32	27		
IL9 SIGNALING%WIKIPATHWAYS_20250310%WP22%HOMO SAPIENS	17	15		
THYMIC STROMAL LYMPHOPOIETIN TSLP SIGNALING%WIKIPATHWAYS_20250310%WP2203%HOMO SAPIENS	37	36		
METASTATIC BRAIN TUMOR%WIKIPATHWAYS_20250310%WP2249%HOMO SAPIENS	13	8		
PILOCYTIC ASTROCYTOMA%WIKIPATHWAYS_20250310%WP2253%HOMO SAPIENS	9	9		
GLIOBLASTOMA SIGNALING%WIKIPATHWAYS_20250310%WP2261%HOMO SAPIENS	82	80		
ANDROGEN RECEPTOR NETWORK IN PROSTATE CANCER%WIKIPATHWAYS_20250310%WP2263%HOMO SAPIENS	109	100		
SYNAPTIC VESICLE PATHWAY%WIKIPATHWAYS_20250310%WP2267%HOMO SAPIENS	51	40		
PATHOGENIC ESCHERICHIA COLI INFECTION%WIKIPATHWAYS_20250310%WP2272%HOMO SAPIENS	55	51		
GLIAL CELL DIFFERENTIATION%WIKIPATHWAYS_20250310%WP2276%HOMO SAPIENS	8		Rejected!	
DRUG INDUCTION OF BILE ACID PATHWAY%WIKIPATHWAYS_20250310%WP2289%HOMO SAPIENS	17	10		
IRINOTECAN PATHWAY%WIKIPATHWAYS_20250310%WP229%HOMO SAPIENS	12	11		
RALA DOWNSTREAM REGULATED GENES%WIKIPATHWAYS_20250310%WP2290%HOMO SAPIENS	12	12		
DEREGULATION OF RAB AND RAB EFFECTOR GENES IN BLADDER CANCER%WIKIPATHWAYS_20250310%WP2291%HOMO SAPIENS	16	15		
B CELL RECEPTOR SIGNALING%WIKIPATHWAYS_20250310%WP23%HOMO SAPIENS	92	92		
TNF ALPHA SIGNALING%WIKIPATHWAYS_20250310%WP231%HOMO SAPIENS	89	87		
AGE RAGE PATHWAY%WIKIPATHWAYS_20250310%WP2324%HOMO SAPIENS	66	64		
ALLOGRAFT REJECTION%WIKIPATHWAYS_20250310%WP2328%HOMO SAPIENS	90	72		
IL11 SIGNALING%WIKIPATHWAYS_20250310%WP2332%HOMO SAPIENS	44	43		
TRANS SULFURATION PATHWAY%WIKIPATHWAYS_20250310%WP2333%HOMO SAPIENS	11	11		
MIRNA BIOGENESIS%WIKIPATHWAYS_20250310%WP2338%HOMO SAPIENS	6	6		
CORTICOTROPIN RELEASING HORMONE SIGNALING%WIKIPATHWAYS_20250310%WP2355%HOMO SAPIENS	93	80		
PARKIN UBIQUITIN PROTEASOMAL SYSTEM PATHWAY%WIKIPATHWAYS_20250310%WP2359%HOMO SAPIENS	71	66		
ADIPOGENESIS%WIKIPATHWAYS_20250310%WP236%HOMO SAPIENS	131	112		
GASTRIC CANCER NETWORK 1%WIKIPATHWAYS_20250310%WP2361%HOMO SAPIENS	28	25		
GASTRIC CANCER NETWORK 2%WIKIPATHWAYS_20250310%WP2363%HOMO SAPIENS	31	30		
BUTYRATE INDUCED HISTONE ACETYLATION%WIKIPATHWAYS_20250310%WP2366%HOMO SAPIENS	2		Rejected!	
HISTONE MODIFICATIONS%WIKIPATHWAYS_20250310%WP2369%HOMO SAPIENS	65	40		
PARKINSON 39 S DISEASE PATHWAY%WIKIPATHWAYS_20250310%WP2371%HOMO SAPIENS	38	35		
ONCOSTATIN M SIGNALING%WIKIPATHWAYS_20250310%WP2374%HOMO SAPIENS	56	55		
BRAIN DERIVED NEUROTROPHIC FACTOR BDNF SIGNALING%WIKIPATHWAYS_20250310%WP2380%HOMO SAPIENS	137	131		
PEPTIDE GPCRS%WIKIPATHWAYS_20250310%WP24%HOMO SAPIENS	75	37		
CARDIAC PROGENITOR DIFFERENTIATION%WIKIPATHWAYS_20250310%WP2406%HOMO SAPIENS	53	27		
ONE CARBON METABOLISM%WIKIPATHWAYS_20250310%WP241%HOMO SAPIENS	29	29		
SPINAL CORD INJURY%WIKIPATHWAYS_20250310%WP2431%HOMO SAPIENS	120	93		
QUERCETIN AND NF KB AP 1 INDUCED APOPTOSIS%WIKIPATHWAYS_20250310%WP2435%HOMO SAPIENS	16	14		
DOPAMINE METABOLISM%WIKIPATHWAYS_20250310%WP2436%HOMO SAPIENS	13	10		
ALPHA 6 BETA 4 SIGNALING%WIKIPATHWAYS_20250310%WP244%HOMO SAPIENS	33	33		
RETINOBLASTOMA GENE IN CANCER%WIKIPATHWAYS_20250310%WP2446%HOMO SAPIENS	89	88		
AMYOTROPHIC LATERAL SCLEROSIS ALS %WIKIPATHWAYS_20250310%WP2447%HOMO SAPIENS	39	35		
TCA CYCLE AND DEFICIENCY OF PYRUVATE DEHYDROGENASE COMPLEX PDHC %WIKIPATHWAYS_20250310%WP2453%HOMO SAPIENS	16	16		
HIF1A AND PPARG IN HYPERTROPHIC CARDIOMYOPATHY%WIKIPATHWAYS_20250310%WP2456%HOMO SAPIENS	9	9		
SMALL LIGAND GPCRS%WIKIPATHWAYS_20250310%WP247%HOMO SAPIENS	19	16		
NAD BIOSYNTHESIS II FROM TRYPTOPHAN%WIKIPATHWAYS_20250310%WP2485%HOMO SAPIENS	8	8		
DICLOFENAC METABOLIC PATHWAY%WIKIPATHWAYS_20250310%WP2491%HOMO SAPIENS	4		Rejected!	
NANOMATERIAL INDUCED APOPTOSIS%WIKIPATHWAYS_20250310%WP2507%HOMO SAPIENS	20	20		
NANOPARTICLE TRIGGERED AUTOPHAGIC CELL DEATH%WIKIPATHWAYS_20250310%WP2509%HOMO SAPIENS	23	22		
NANOPARTICLE TRIGGERED REGULATED NECROSIS%WIKIPATHWAYS_20250310%WP2513%HOMO SAPIENS	12	12		
ATM SIGNALING%WIKIPATHWAYS_20250310%WP2516%HOMO SAPIENS	40	39		
TRANS SULFURATION ONE CARBON METABOLISM AND RELATED PATHWAYS%WIKIPATHWAYS_20250310%WP2525%HOMO SAPIENS	69	63		
PDGF PATHWAY%WIKIPATHWAYS_20250310%WP2526%HOMO SAPIENS	40	40		
GLYCEROPHOSPHOLIPID BIOSYNTHETIC PATHWAY%WIKIPATHWAYS_20250310%WP2533%HOMO SAPIENS	30	29		
COLCHICINE METABOLIC PATHWAY%WIKIPATHWAYS_20250310%WP2536%HOMO SAPIENS	1		Rejected!	
APOPTOSIS%WIKIPATHWAYS_20250310%WP254%HOMO SAPIENS	88	82		
SULINDAC METABOLIC PATHWAY%WIKIPATHWAYS_20250310%WP2542%HOMO SAPIENS	5		Rejected!	
POLYCYSTIC KIDNEY DISEASE PATHWAY%WIKIPATHWAYS_20250310%WP2571%HOMO SAPIENS	85	74		
PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS FSGS %WIKIPATHWAYS_20250310%WP2572%HOMO SAPIENS	72	68		
T CELL RECEPTOR AND CO STIMULATORY SIGNALING%WIKIPATHWAYS_20250310%WP2583%HOMO SAPIENS	28	27		
ARYL HYDROCARBON RECEPTOR PATHWAY%WIKIPATHWAYS_20250310%WP2586%HOMO SAPIENS	46	42		
GASTRIC ACID PRODUCTION%WIKIPATHWAYS_20250310%WP2596%HOMO SAPIENS	12		Rejected!	
S1P RECEPTOR SIGNAL TRANSDUCTION%WIKIPATHWAYS_20250310%WP26%HOMO SAPIENS	25	25		
EBSTEIN BARR VIRUS LMP1 SIGNALING%WIKIPATHWAYS_20250310%WP262%HOMO SAPIENS	23	21		
COMMON PATHWAYS UNDERLYING DRUG ADDICTION%WIKIPATHWAYS_20250310%WP2636%HOMO SAPIENS	41	30		
INTERLEUKIN 1 IL 1 STRUCTURAL PATHWAY%WIKIPATHWAYS_20250310%WP2637%HOMO SAPIENS	49	48		
ARIPIPRAZOLE METABOLIC PATHWAY%WIKIPATHWAYS_20250310%WP2640%HOMO SAPIENS	2		Rejected!	
NANOPARTICLE MEDIATED ACTIVATION OF RECEPTOR SIGNALING%WIKIPATHWAYS_20250310%WP2643%HOMO SAPIENS	28	27		
HEROIN METABOLISM%WIKIPATHWAYS_20250310%WP2645%HOMO SAPIENS	3		Rejected!	
LIDOCAINE METABOLISM%WIKIPATHWAYS_20250310%WP2646%HOMO SAPIENS	2		Rejected!	
NOTCH SIGNALING%WIKIPATHWAYS_20250310%WP268%HOMO SAPIENS	45	41		
BLOOD CLOTTING CASCADE%WIKIPATHWAYS_20250310%WP272%HOMO SAPIENS	22	17		
CARDIAC HYPERTROPHIC RESPONSE%WIKIPATHWAYS_20250310%WP2795%HOMO SAPIENS	54	51		
SELENIUM METABOLISM AND SELENOPROTEINS%WIKIPATHWAYS_20250310%WP28%HOMO SAPIENS	47	44		
EXRNA MECHANISM OF ACTION AND BIOGENESIS%WIKIPATHWAYS_20250310%WP2805%HOMO SAPIENS	6	6		
COMPLEMENT SYSTEM%WIKIPATHWAYS_20250310%WP2806%HOMO SAPIENS	95	76		
MAMMARY GLAND DEVELOPMENT EMBRYONIC DEVELOPMENT STAGE 1 OF 4%WIKIPATHWAYS_20250310%WP2813%HOMO SAPIENS	18	16		
MAMMARY GLAND DEVELOPMENT PUBERTY STAGE 2 OF 4%WIKIPATHWAYS_20250310%WP2814%HOMO SAPIENS	13	12		
MAMMARY GLAND DEVELOPMENT INVOLUTION STAGE 4 OF 4%WIKIPATHWAYS_20250310%WP2815%HOMO SAPIENS	10	10		
FELBAMATE METABOLISM%WIKIPATHWAYS_20250310%WP2816%HOMO SAPIENS	2		Rejected!	
MAMMARY GLAND DEVELOPMENT PREGNANCY AND LACTATION STAGE 3 OF 4%WIKIPATHWAYS_20250310%WP2817%HOMO SAPIENS	44	38		
COCAINE METABOLISM%WIKIPATHWAYS_20250310%WP2826%HOMO SAPIENS	4		Rejected!	
BLADDER CANCER%WIKIPATHWAYS_20250310%WP2828%HOMO SAPIENS	40	37		
HAIR FOLLICLE DEVELOPMENT ORGANOGENESIS STAGE 2 OF 3%WIKIPATHWAYS_20250310%WP2839%HOMO SAPIENS	32	30		
HAIR FOLLICLE DEVELOPMENT CYTODIFFERENTIATION STAGE 3 OF 3%WIKIPATHWAYS_20250310%WP2840%HOMO SAPIENS	87	56		
PCSK9 MEDIATED LDL RECEPTOR DEGRADATION%WIKIPATHWAYS_20250310%WP2846%HOMO SAPIENS	2		Rejected!	
PLURIPOTENT STEM CELL DIFFERENTIATION PATHWAY%WIKIPATHWAYS_20250310%WP2848%HOMO SAPIENS	48	30		
HEMATOPOIETIC STEM CELL DIFFERENTIATION%WIKIPATHWAYS_20250310%WP2849%HOMO SAPIENS	59	43		
ENDODERM DIFFERENTIATION%WIKIPATHWAYS_20250310%WP2853%HOMO SAPIENS	144	119		
GENE REGULATORY NETWORK MODELING SOMITOGENESIS %WIKIPATHWAYS_20250310%WP2854%HOMO SAPIENS	11	6		
DOPAMINERGIC NEUROGENESIS%WIKIPATHWAYS_20250310%WP2855%HOMO SAPIENS	30	13		
MESODERMAL COMMITMENT PATHWAY%WIKIPATHWAYS_20250310%WP2857%HOMO SAPIENS	147	124		
ECTODERM DIFFERENTIATION%WIKIPATHWAYS_20250310%WP2858%HOMO SAPIENS	141	122		
IL3 SIGNALING%WIKIPATHWAYS_20250310%WP286%HOMO SAPIENS	49	46		
APOPTOSIS RELATED NETWORK DUE TO ALTERED NOTCH3 IN OVARIAN CANCER%WIKIPATHWAYS_20250310%WP2864%HOMO SAPIENS	53	53		
IL1 AND MEGAKARYOCYTES IN OBESITY%WIKIPATHWAYS_20250310%WP2865%HOMO SAPIENS	24	21		
TCA CYCLE NUTRIENT USE AND INVASIVENESS OF OVARIAN CANCER%WIKIPATHWAYS_20250310%WP2868%HOMO SAPIENS	5	5		
EXTRACELLULAR VESICLE MEDIATED SIGNALING IN RECIPIENT CELLS%WIKIPATHWAYS_20250310%WP2870%HOMO SAPIENS	29	27		
ARYL HYDROCARBON RECEPTOR PATHWAY%WIKIPATHWAYS_20250310%WP2873%HOMO SAPIENS	45	36		
LIVER X RECEPTOR PATHWAY%WIKIPATHWAYS_20250310%WP2874%HOMO SAPIENS	10	8		
CONSTITUTIVE ANDROSTANE RECEPTOR PATHWAY%WIKIPATHWAYS_20250310%WP2875%HOMO SAPIENS	31	28		
PREGNANE X RECEPTOR PATHWAY%WIKIPATHWAYS_20250310%WP2876%HOMO SAPIENS	32	27		
VITAMIN D RECEPTOR PATHWAY%WIKIPATHWAYS_20250310%WP2877%HOMO SAPIENS	187	139		
PPAR ALPHA PATHWAY%WIKIPATHWAYS_20250310%WP2878%HOMO SAPIENS	26	21		
FARNESOID X RECEPTOR PATHWAY%WIKIPATHWAYS_20250310%WP2879%HOMO SAPIENS	19	12		
NOD LIKE RECEPTOR NLR SIGNALING%WIKIPATHWAYS_20250310%WP288%HOMO SAPIENS	9	9		
GLUCOCORTICOID RECEPTOR PATHWAY%WIKIPATHWAYS_20250310%WP2880%HOMO SAPIENS	70	62		
ESTROGEN RECEPTOR PATHWAY%WIKIPATHWAYS_20250310%WP2881%HOMO SAPIENS	13	11		
NUCLEAR RECEPTORS META PATHWAY%WIKIPATHWAYS_20250310%WP2882%HOMO SAPIENS	314	265		
NRF2 PATHWAY%WIKIPATHWAYS_20250310%WP2884%HOMO SAPIENS	141	123		
OXYTOCIN SIGNALING%WIKIPATHWAYS_20250310%WP2889%HOMO SAPIENS	4		Rejected!	
MYOMETRIAL RELAXATION AND CONTRACTION PATHWAYS%WIKIPATHWAYS_20250310%WP289%HOMO SAPIENS	156	139		
DIFFERENTIATION OF WHITE AND BROWN ADIPOCYTE%WIKIPATHWAYS_20250310%WP2895%HOMO SAPIENS	25	20		
MIRNA TARGETS IN ECM AND MEMBRANE RECEPTORS%WIKIPATHWAYS_20250310%WP2911%HOMO SAPIENS	38	26		
INTERACTOME OF POLYCOMB REPRESSIVE COMPLEX 2 PRC2 %WIKIPATHWAYS_20250310%WP2916%HOMO SAPIENS	16	16		
DDX1 AS A REGULATORY COMPONENT OF THE DROSHA MICROPROCESSOR%WIKIPATHWAYS_20250310%WP2942%HOMO SAPIENS	7	7		
HYPOXIA MEDIATED EMT AND STEMNESS%WIKIPATHWAYS_20250310%WP2943%HOMO SAPIENS	2		Rejected!	
NUCLEAR RECEPTORS IN LIPID METABOLISM AND TOXICITY%WIKIPATHWAYS_20250310%WP299%HOMO SAPIENS	35	27		
TRANSCRIPTIONAL ACTIVATION BY NRF2 IN RESPONSE TO PHYTOCHEMICALS%WIKIPATHWAYS_20250310%WP3%HOMO SAPIENS	15	14		
KIT RECEPTOR SIGNALING%WIKIPATHWAYS_20250310%WP304%HOMO SAPIENS	53	53		
FOCAL ADHESION%WIKIPATHWAYS_20250310%WP306%HOMO SAPIENS	199	187		
HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING%WIKIPATHWAYS_20250310%WP313%HOMO SAPIENS	34	34		
FAS LIGAND PATHWAY AND STRESS INDUCTION OF HEAT SHOCK PROTEINS%WIKIPATHWAYS_20250310%WP314%HOMO SAPIENS	43	41		
OSTEOBLAST SIGNALING%WIKIPATHWAYS_20250310%WP322%HOMO SAPIENS	14	10		
TRIACYLGLYCERIDE SYNTHESIS%WIKIPATHWAYS_20250310%WP325%HOMO SAPIENS	24	21		
COPPER HOMEOSTASIS%WIKIPATHWAYS_20250310%WP3286%HOMO SAPIENS	51	49		
OVERVIEW OF NANOPARTICLE EFFECTS%WIKIPATHWAYS_20250310%WP3287%HOMO SAPIENS	19	17		
EV RELEASE FROM CARDIAC CELLS AND THEIR FUNCTIONAL EFFECTS%WIKIPATHWAYS_20250310%WP3297%HOMO SAPIENS	7		Rejected!	
MELATONIN METABOLISM AND EFFECTS%WIKIPATHWAYS_20250310%WP3298%HOMO SAPIENS	35	30		
LET 7 INHIBITION OF ES CELL REPROGRAMMING%WIKIPATHWAYS_20250310%WP3299%HOMO SAPIENS	15	6		
DUAL HIJACK MODEL OF VIF IN HIV INFECTION%WIKIPATHWAYS_20250310%WP3300%HOMO SAPIENS	9	8		
MFAP5 MEDIATED OVARIAN CANCER CELL MOTILITY AND INVASIVENESS%WIKIPATHWAYS_20250310%WP3301%HOMO SAPIENS	13	13		
EIF5A REGULATION IN RESPONSE TO INHIBITION OF THE NUCLEAR EXPORT SYSTEM%WIKIPATHWAYS_20250310%WP3302%HOMO SAPIENS	4		Rejected!	
RAC1 PAK1 P38 MMP2 PATHWAY%WIKIPATHWAYS_20250310%WP3303%HOMO SAPIENS	68	65		
GPCRS CLASS B SECRETIN LIKE%WIKIPATHWAYS_20250310%WP334%HOMO SAPIENS	24	17		
SENESCENCE ASSOCIATED SECRETORY PHENOTYPE SASP %WIKIPATHWAYS_20250310%WP3391%HOMO SAPIENS	113	63		
OVARIAN INFERTILITY%WIKIPATHWAYS_20250310%WP34%HOMO SAPIENS	39	31		
FTO OBESITY VARIANT MECHANISM%WIKIPATHWAYS_20250310%WP3407%HOMO SAPIENS	8	6		
EVOLOCUMAB MECHANISM TO REDUCE LDL CHOLESTEROL%WIKIPATHWAYS_20250310%WP3408%HOMO SAPIENS	2		Rejected!	
NOTCH1 REGULATION OF ENDOTHELIAL CELL CALCIFICATION%WIKIPATHWAYS_20250310%WP3413%HOMO SAPIENS	17	16		
INITIATION OF TRANSCRIPTION AND TRANSLATION ELONGATION AT THE HIV 1 LTR%WIKIPATHWAYS_20250310%WP3414%HOMO SAPIENS	32	31		
G PROTEIN SIGNALING%WIKIPATHWAYS_20250310%WP35%HOMO SAPIENS	91	85		
PRE IMPLANTATION EMBRYO%WIKIPATHWAYS_20250310%WP3527%HOMO SAPIENS	58	39		
ZINC HOMEOSTASIS%WIKIPATHWAYS_20250310%WP3529%HOMO SAPIENS	36	30		
FATTY ACID BIOSYNTHESIS%WIKIPATHWAYS_20250310%WP357%HOMO SAPIENS	22	22		
METHIONINE DE NOVO AND SALVAGE PATHWAY%WIKIPATHWAYS_20250310%WP3580%HOMO SAPIENS	22	21		
MECP2 AND ASSOCIATED RETT SYNDROME%WIKIPATHWAYS_20250310%WP3584%HOMO SAPIENS	74	58		
CYTOSINE METHYLATION%WIKIPATHWAYS_20250310%WP3585%HOMO SAPIENS	8	8		
SLEEP REGULATION%WIKIPATHWAYS_20250310%WP3591%HOMO SAPIENS	38	20		
MICRORNA FOR TARGETING CANCER GROWTH AND VASCULARIZATION IN GLIOBLASTOMA%WIKIPATHWAYS_20250310%WP3593%HOMO SAPIENS	8	7		
CIRCADIAN RHYTHM GENES%WIKIPATHWAYS_20250310%WP3594%HOMO SAPIENS	201	158		
MIR 124 PREDICTED INTERACTIONS WITH CELL CYCLE AND DIFFERENTIATION %WIKIPATHWAYS_20250310%WP3595%HOMO SAPIENS	6	6		
MIR 517 RELATIONSHIP WITH ARCN1 AND USP1%WIKIPATHWAYS_20250310%WP3596%HOMO SAPIENS	5	5		
TRANSCRIPTION FACTOR REGULATION IN ADIPOGENESIS%WIKIPATHWAYS_20250310%WP3599%HOMO SAPIENS	22	18		
LIPID PARTICLES COMPOSITION%WIKIPATHWAYS_20250310%WP3601%HOMO SAPIENS	10	7		
PHOTODYNAMIC THERAPY INDUCED AP 1 SURVIVAL SIGNALING%WIKIPATHWAYS_20250310%WP3611%HOMO SAPIENS	51	46		
PHOTODYNAMIC THERAPY INDUCED NFE2L2 NRF2 SURVIVAL SIGNALING%WIKIPATHWAYS_20250310%WP3612%HOMO SAPIENS	23	23		
PHOTODYNAMIC THERAPY INDUCED UNFOLDED PROTEIN RESPONSE%WIKIPATHWAYS_20250310%WP3613%HOMO SAPIENS	27	26		
PHOTODYNAMIC THERAPY INDUCED HIF 1 SURVIVAL SIGNALING%WIKIPATHWAYS_20250310%WP3614%HOMO SAPIENS	38	36		
PHOTODYNAMIC THERAPY INDUCED NF KB SURVIVAL SIGNALING%WIKIPATHWAYS_20250310%WP3617%HOMO SAPIENS	35	29		
LUNG FIBROSIS%WIKIPATHWAYS_20250310%WP3624%HOMO SAPIENS	63	49		
GUT LIVER INDOLE METABOLISM %WIKIPATHWAYS_20250310%WP3627%HOMO SAPIENS	1		Rejected!	
WNT SIGNALING%WIKIPATHWAYS_20250310%WP363%HOMO SAPIENS	47	44		
NAD METABOLISM SIRTUINS AND AGING%WIKIPATHWAYS_20250310%WP3630%HOMO SAPIENS	11	11		
CAFFEINE AND THEOBROMINE METABOLISM%WIKIPATHWAYS_20250310%WP3633%HOMO SAPIENS	4		Rejected!	
INSULIN SIGNALING IN ADIPOCYTES NORMAL CONDITION %WIKIPATHWAYS_20250310%WP3634%HOMO SAPIENS	8	8		
INSULIN SIGNALING IN ADIPOCYTES DIABETIC CONDITION %WIKIPATHWAYS_20250310%WP3635%HOMO SAPIENS	8	8		
IL6 SIGNALING%WIKIPATHWAYS_20250310%WP364%HOMO SAPIENS	43	41		
IMATINIB AND CHRONIC MYELOID LEUKEMIA%WIKIPATHWAYS_20250310%WP3640%HOMO SAPIENS	20	20		
NAD METABOLISM%WIKIPATHWAYS_20250310%WP3644%HOMO SAPIENS	16	16		
NAD BIOSYNTHETIC PATHWAYS%WIKIPATHWAYS_20250310%WP3645%HOMO SAPIENS	22	22		
HEPATITIS C AND HEPATOCELLULAR CARCINOMA%WIKIPATHWAYS_20250310%WP3646%HOMO SAPIENS	56	46		
PATHWAYS AFFECTED IN ADENOID CYSTIC CARCINOMA%WIKIPATHWAYS_20250310%WP3651%HOMO SAPIENS	65	60		
HYPOTHETICAL CRANIOFACIAL DEVELOPMENT PATHWAY%WIKIPATHWAYS_20250310%WP3655%HOMO SAPIENS	8	7		
INTERLEUKIN 1 INDUCED ACTIVATION OF NF KB%WIKIPATHWAYS_20250310%WP3656%HOMO SAPIENS	10	9		
HEMATOPOIETIC STEM CELL GENE REGULATION BY GABP ALPHA BETA COMPLEX%WIKIPATHWAYS_20250310%WP3657%HOMO SAPIENS	21	20		
WNT BETA CATENIN SIGNALING IN LEUKEMIA%WIKIPATHWAYS_20250310%WP3658%HOMO SAPIENS	26	23		
TGF BETA SIGNALING PATHWAY%WIKIPATHWAYS_20250310%WP366%HOMO SAPIENS	132	128		
REGULATION OF WNT B CATENIN SIGNALING BY SMALL MOLECULE COMPOUNDS%WIKIPATHWAYS_20250310%WP3664%HOMO SAPIENS	17	16		
METABOLISM OF DICHLOROETHYLENE BY CYP450%WIKIPATHWAYS_20250310%WP3666%HOMO SAPIENS	1		Rejected!	
HYPOTHESIZED PATHWAYS IN PATHOGENESIS OF CARDIOVASCULAR DISEASE%WIKIPATHWAYS_20250310%WP3668%HOMO SAPIENS	25	25		
INTERACTIONS BETWEEN LOXL4 AND OXIDATIVE STRESS PATHWAY%WIKIPATHWAYS_20250310%WP3670%HOMO SAPIENS	18	17		
LNCRNA MEDIATED MECHANISMS OF THERAPEUTIC RESISTANCE%WIKIPATHWAYS_20250310%WP3672%HOMO SAPIENS	6	5		
TGIF DISRUPTION OF SHH SIGNALING%WIKIPATHWAYS_20250310%WP3674%HOMO SAPIENS	9	5		
BDNF TRKB SIGNALING%WIKIPATHWAYS_20250310%WP3676%HOMO SAPIENS	33	31		
AMPLIFICATION AND EXPANSION OF ONCOGENIC PATHWAYS AS METASTATIC TRAITS%WIKIPATHWAYS_20250310%WP3678%HOMO SAPIENS	17	16		
CELL TYPE DEPENDENT SELECTIVITY OF CCK2R SIGNALING%WIKIPATHWAYS_20250310%WP3679%HOMO SAPIENS	13	11		
MITOCHONDRIAL LONG CHAIN FATTY ACID BETA OXIDATION%WIKIPATHWAYS_20250310%WP368%HOMO SAPIENS	17	17		
PHYSICO CHEMICAL FEATURES AND TOXICITY ASSOCIATED PATHWAYS%WIKIPATHWAYS_20250310%WP3680%HOMO SAPIENS	66	61		
MAPK SIGNALING%WIKIPATHWAYS_20250310%WP382%HOMO SAPIENS	247	213		
STRIATED MUSCLE CONTRACTION PATHWAY%WIKIPATHWAYS_20250310%WP383%HOMO SAPIENS	38	27		
APOPTOSIS MODULATION BY HSP70%WIKIPATHWAYS_20250310%WP384%HOMO SAPIENS	19	19		
PI3K AKT MTOR SIGNALING AND THERAPEUTIC OPPORTUNITIES IN PROSTATE CANCER%WIKIPATHWAYS_20250310%WP3844%HOMO SAPIENS	32	32		
CANONICAL AND NON CANONICAL NOTCH SIGNALING%WIKIPATHWAYS_20250310%WP3845%HOMO SAPIENS	27	24		
MAPK AND NFKB SIGNALING INHIBITED BY YERSINIA YOPJ%WIKIPATHWAYS_20250310%WP3849%HOMO SAPIENS	12	12		
FACTORS AND PATHWAYS AFFECTING INSULIN LIKE GROWTH FACTOR IGF1 AKT SIGNALING%WIKIPATHWAYS_20250310%WP3850%HOMO SAPIENS	36	35		
TLR4 SIGNALING AND TOLERANCE%WIKIPATHWAYS_20250310%WP3851%HOMO SAPIENS	28	26		
ERK PATHWAY IN HUNTINGTON 39 S DISEASE%WIKIPATHWAYS_20250310%WP3853%HOMO SAPIENS	17	17		
TOLL LIKE RECEPTOR SIGNALING RELATED TO MYD88%WIKIPATHWAYS_20250310%WP3858%HOMO SAPIENS	31	31		
TGF BETA SIGNALING IN THYROID CELLS FOR EPITHELIAL MESENCHYMAL TRANSITION%WIKIPATHWAYS_20250310%WP3859%HOMO SAPIENS	19	19		
T CELL ANTIGEN RECEPTOR TCR PATHWAY DURING STAPHYLOCOCCUS AUREUS INFECTION%WIKIPATHWAYS_20250310%WP3863%HOMO SAPIENS	62	56		
NOVEL INTRACELLULAR COMPONENTS OF RIG I LIKE RECEPTOR PATHWAY%WIKIPATHWAYS_20250310%WP3865%HOMO SAPIENS	60	55		
CANNABINOID RECEPTOR SIGNALING%WIKIPATHWAYS_20250310%WP3869%HOMO SAPIENS	29	25		
VALPROIC ACID PATHWAY%WIKIPATHWAYS_20250310%WP3871%HOMO SAPIENS	12	11		
APOPTOSIS REGULATION BY PARATHYROID HORMONE RELATED PROTEIN%WIKIPATHWAYS_20250310%WP3872%HOMO SAPIENS	25	22		
RIOK1 AND RIOK2 IN EGFR AND PI3K MEDIATED TUMORIGENESIS%WIKIPATHWAYS_20250310%WP3873%HOMO SAPIENS	15	15		
CANONICAL AND NON CANONICAL TGF B SIGNALING%WIKIPATHWAYS_20250310%WP3874%HOMO SAPIENS	17	17		
ATR SIGNALING%WIKIPATHWAYS_20250310%WP3875%HOMO SAPIENS	11	11		
BMP2 WNT4 FOXO1 PATHWAY IN PRIMARY ENDOMETRIAL STROMAL CELL DIFFERENTIATION%WIKIPATHWAYS_20250310%WP3876%HOMO SAPIENS	13	10		
MYD88 DISTINCT INPUT OUTPUT PATHWAY%WIKIPATHWAYS_20250310%WP3877%HOMO SAPIENS	18	17		
ATM SIGNALING IN DEVELOPMENT AND DISEASE %WIKIPATHWAYS_20250310%WP3878%HOMO SAPIENS	47	47		
4 HYDROXYTAMOXIFEN DEXAMETHASONE AND RETINOIC ACIDS REGULATION OF P27 EXPRESSION%WIKIPATHWAYS_20250310%WP3879%HOMO SAPIENS	25	25		
VEGFA VEGFR2 SIGNALING%WIKIPATHWAYS_20250310%WP3888%HOMO SAPIENS	432	418		
NANOMATERIAL INDUCED INFLAMMASOME ACTIVATION%WIKIPATHWAYS_20250310%WP3890%HOMO SAPIENS	7	6		
BENZENE METABOLISM%WIKIPATHWAYS_20250310%WP3891%HOMO SAPIENS	6	5		
DEVELOPMENT OF PULMONARY DENDRITIC CELLS AND MACROPHAGE SUBSETS%WIKIPATHWAYS_20250310%WP3892%HOMO SAPIENS	13	11		
DEVELOPMENT AND HETEROGENEITY OF THE ILC FAMILY%WIKIPATHWAYS_20250310%WP3893%HOMO SAPIENS	32	20		
DENGUE 2 INTERACTIONS WITH COMPLEMENT AND COAGULATION CASCADES%WIKIPATHWAYS_20250310%WP3896%HOMO SAPIENS	59	52		
MITOCHONDRIAL GENE EXPRESSION%WIKIPATHWAYS_20250310%WP391%HOMO SAPIENS	19	19		
ANGIOPOIETIN LIKE PROTEIN 8 REGULATORY PATHWAY%WIKIPATHWAYS_20250310%WP3915%HOMO SAPIENS	132	127		
HFE EFFECT ON HEPCIDIN PRODUCTION%WIKIPATHWAYS_20250310%WP3924%HOMO SAPIENS	7		Rejected!	
AMINO ACID METABOLISM%WIKIPATHWAYS_20250310%WP3925%HOMO SAPIENS	92	82		
APOE AND MIR 146 IN INFLAMMATION AND ATHEROSCLEROSIS%WIKIPATHWAYS_20250310%WP3926%HOMO SAPIENS	9	8		
BMP SIGNALING IN EYELID DEVELOPMENT%WIKIPATHWAYS_20250310%WP3927%HOMO SAPIENS	20	19		
CHEMOKINE SIGNALING%WIKIPATHWAYS_20250310%WP3929%HOMO SAPIENS	165	141		
EDA SIGNALING IN HAIR FOLLICLE DEVELOPMENT%WIKIPATHWAYS_20250310%WP3930%HOMO SAPIENS	14	11		
EMBRYONIC STEM CELL PLURIPOTENCY PATHWAYS%WIKIPATHWAYS_20250310%WP3931%HOMO SAPIENS	118	98		
FOCAL ADHESION PI3K AKT MTOR SIGNALING%WIKIPATHWAYS_20250310%WP3932%HOMO SAPIENS	304	267		
KENNEDY PATHWAY FROM SPHINGOLIPIDS%WIKIPATHWAYS_20250310%WP3933%HOMO SAPIENS	14	13		
LEPTIN AND ADIPONECTIN%WIKIPATHWAYS_20250310%WP3934%HOMO SAPIENS	10	8		
LEPTIN INSULIN SIGNALING OVERLAP%WIKIPATHWAYS_20250310%WP3935%HOMO SAPIENS	17	14		
MICROGLIA PATHOGEN PHAGOCYTOSIS PATHWAY%WIKIPATHWAYS_20250310%WP3937%HOMO SAPIENS	40	39		
MIR 222 IN EXERCISE INDUCED CARDIAC GROWTH%WIKIPATHWAYS_20250310%WP3938%HOMO SAPIENS	4		Rejected!	
OXIDATIVE DAMAGE RESPONSE%WIKIPATHWAYS_20250310%WP3941%HOMO SAPIENS	40	40		
PPAR SIGNALING%WIKIPATHWAYS_20250310%WP3942%HOMO SAPIENS	50	42		
ROBO4 AND VEGF SIGNALING CROSSTALK%WIKIPATHWAYS_20250310%WP3943%HOMO SAPIENS	6	6		
SEROTONIN AND ANXIETY RELATED EVENTS%WIKIPATHWAYS_20250310%WP3944%HOMO SAPIENS	14	8		
TYROBP CAUSAL NETWORK IN MICROGLIA%WIKIPATHWAYS_20250310%WP3945%HOMO SAPIENS	62	58		
SEROTONIN AND ANXIETY%WIKIPATHWAYS_20250310%WP3947%HOMO SAPIENS	18	13		
IL4 SIGNALING%WIKIPATHWAYS_20250310%WP395%HOMO SAPIENS	50	49		
MRNA PROTEIN AND METABOLITE INDUCATION PATHWAY BY CYCLOSPORIN A%WIKIPATHWAYS_20250310%WP3953%HOMO SAPIENS	7	6		
GPR40 PATHWAY%WIKIPATHWAYS_20250310%WP3958%HOMO SAPIENS	15	13		
DNA IR DOUBLE STRAND BREAKS AND CELLULAR RESPONSE VIA ATM%WIKIPATHWAYS_20250310%WP3959%HOMO SAPIENS	55	52		
MEVALONATE PATHWAY%WIKIPATHWAYS_20250310%WP3963%HOMO SAPIENS	7	7		
LIPID METABOLISM PATHWAY%WIKIPATHWAYS_20250310%WP3965%HOMO SAPIENS	29	28		
MIR 509 3P ALTERATION OF YAP1 ECM AXIS%WIKIPATHWAYS_20250310%WP3967%HOMO SAPIENS	18	16		
H19 RB E2F1 AND CDK BETA CATENIN IN COLORECTAL CANCER%WIKIPATHWAYS_20250310%WP3969%HOMO SAPIENS	14	14		
OSX AND MIRNAS IN TOOTH DEVELOPMENT%WIKIPATHWAYS_20250310%WP3971%HOMO SAPIENS	34	14		
PDGFR BETA PATHWAY%WIKIPATHWAYS_20250310%WP3972%HOMO SAPIENS	29	29		
MIRNA REGULATION OF PROSTATE CANCER SIGNALING%WIKIPATHWAYS_20250310%WP3981%HOMO SAPIENS	31	30		
MIRNA REGULATION OF P53 PATHWAY IN PROSTATE CANCER%WIKIPATHWAYS_20250310%WP3982%HOMO SAPIENS	31	23		
WNT SIGNALING AND PLURIPOTENCY%WIKIPATHWAYS_20250310%WP399%HOMO SAPIENS	102	89		
PRION DISEASE PATHWAY%WIKIPATHWAYS_20250310%WP3995%HOMO SAPIENS	33	32		
ETHANOL EFFECTS ON HISTONE MODIFICATIONS%WIKIPATHWAYS_20250310%WP3996%HOMO SAPIENS	31	31		
PRADER WILLI AND ANGELMAN SYNDROME%WIKIPATHWAYS_20250310%WP3998%HOMO SAPIENS	110	77		
P38 MAPK SIGNALING%WIKIPATHWAYS_20250310%WP400%HOMO SAPIENS	35	34		
NO CGMP PKG MEDIATED NEUROPROTECTION%WIKIPATHWAYS_20250310%WP4008%HOMO SAPIENS	46	34		
DNA IR DAMAGE AND CELLULAR RESPONSE VIA ATR%WIKIPATHWAYS_20250310%WP4016%HOMO SAPIENS	81	79		
CLEAR CELL RENAL CELL CARCINOMA PATHWAYS%WIKIPATHWAYS_20250310%WP4018%HOMO SAPIENS	85	83		
PYRIMIDINE METABOLISM%WIKIPATHWAYS_20250310%WP4022%HOMO SAPIENS	84	84		
SCFA AND SKELETAL MUSCLE SUBSTRATE METABOLISM%WIKIPATHWAYS_20250310%WP4030%HOMO SAPIENS	6		Rejected!	
EUKARYOTIC TRANSCRIPTION INITIATION%WIKIPATHWAYS_20250310%WP405%HOMO SAPIENS	42	42		
OXIDATIVE STRESS RESPONSE%WIKIPATHWAYS_20250310%WP408%HOMO SAPIENS	33	29		
EXERCISE INDUCED CIRCADIAN REGULATION%WIKIPATHWAYS_20250310%WP410%HOMO SAPIENS	48	46		
MRNA PROCESSING%WIKIPATHWAYS_20250310%WP411%HOMO SAPIENS	135	125		
FIBRIN COMPLEMENT RECEPTOR 3 SIGNALING%WIKIPATHWAYS_20250310%WP4136%HOMO SAPIENS	44	39		
PI3K AKT MTOR VITAMIN D3 SIGNALING%WIKIPATHWAYS_20250310%WP4141%HOMO SAPIENS	22	19		
METABOLISM OF SPHINGOLIPIDS IN ER AND GOLGI APPARATUS%WIKIPATHWAYS_20250310%WP4142%HOMO SAPIENS	21	19		
MACROPHAGE MARKERS%WIKIPATHWAYS_20250310%WP4146%HOMO SAPIENS	9	9		
PTF1A RELATED REGULATORY PATHWAY%WIKIPATHWAYS_20250310%WP4147%HOMO SAPIENS	11	7		
SPLICING FACTOR NOVA REGULATED SYNAPTIC PROTEINS%WIKIPATHWAYS_20250310%WP4148%HOMO SAPIENS	42	34		
WHITE FAT CELL DIFFERENTIATION%WIKIPATHWAYS_20250310%WP4149%HOMO SAPIENS	32	31		
WNT SIGNALING IN KIDNEY DISEASE%WIKIPATHWAYS_20250310%WP4150%HOMO SAPIENS	37	30		
DEGRADATION PATHWAY OF SPHINGOLIPIDS INCLUDING DISEASES%WIKIPATHWAYS_20250310%WP4153%HOMO SAPIENS	17	16		
ENDOMETRIAL CANCER%WIKIPATHWAYS_20250310%WP4155%HOMO SAPIENS	63	61		
BIOSYNTHESIS AND REGENERATION OF TETRAHYDROBIOPTERIN AND CATABOLISM OF PHENYLALANINE%WIKIPATHWAYS_20250310%WP4156%HOMO SAPIENS	15	12		
GABA METABOLISM AKA GHB %WIKIPATHWAYS_20250310%WP4157%HOMO SAPIENS	11	10		
GABA RECEPTOR SIGNALING%WIKIPATHWAYS_20250310%WP4159%HOMO SAPIENS	31	17		
PI3K AKT SIGNALING%WIKIPATHWAYS_20250310%WP4172%HOMO SAPIENS	340	281		
METABOLISM OF TETRAHYDROCANNABINOL THC %WIKIPATHWAYS_20250310%WP4174%HOMO SAPIENS	2		Rejected!	
SOMATROPH AXIS GH AND ITS RELATIONSHIP TO DIETARY RESTRICTION AND AGING%WIKIPATHWAYS_20250310%WP4186%HOMO SAPIENS	6	6		
MEVALONATE ARM OF CHOLESTEROL BIOSYNTHESIS PATHWAY WITH INHIBITORS%WIKIPATHWAYS_20250310%WP4189%HOMO SAPIENS	2		Rejected!	
MEVALONATE ARM OF CHOLESTEROL BIOSYNTHESIS PATHWAY%WIKIPATHWAYS_20250310%WP4190%HOMO SAPIENS	13	13		
CALORIC RESTRICTION AND AGING%WIKIPATHWAYS_20250310%WP4191%HOMO SAPIENS	8	8		
HORMONAL CONTROL OF PUBERTAL GROWTH SPURT%WIKIPATHWAYS_20250310%WP4194%HOMO SAPIENS	5		Rejected!	
IMMUNE RESPONSE TO TUBERCULOSIS%WIKIPATHWAYS_20250310%WP4197%HOMO SAPIENS	22	22		
TUMOR SUPPRESSOR ACTIVITY OF SMARCB1%WIKIPATHWAYS_20250310%WP4204%HOMO SAPIENS	31	28		
MET IN TYPE 1 PAPILLARY RENAL CELL CARCINOMA%WIKIPATHWAYS_20250310%WP4205%HOMO SAPIENS	59	55		
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CARCINOMA PATHWAY%WIKIPATHWAYS_20250310%WP4206%HOMO SAPIENS	20	19		
TRYPTOPHAN CATABOLISM LEADING TO NAD PRODUCTION%WIKIPATHWAYS_20250310%WP4210%HOMO SAPIENS	16	15		
TRANSCRIPTIONAL CASCADE REGULATING ADIPOGENESIS%WIKIPATHWAYS_20250310%WP4211%HOMO SAPIENS	13	13		
CHROMOSOMAL AND MICROSATELLITE INSTABILITY IN COLORECTAL CANCER %WIKIPATHWAYS_20250310%WP4216%HOMO SAPIENS	73	71		
EBOLA VIRUS INFECTION IN HOST%WIKIPATHWAYS_20250310%WP4217%HOMO SAPIENS	129	123		
MAPK CASCADE%WIKIPATHWAYS_20250310%WP422%HOMO SAPIENS	33	33		
NEUROTRANSMITTER DISORDERS%WIKIPATHWAYS_20250310%WP4220%HOMO SAPIENS	10	6		
PHOSPHODIESTERASES IN NEURONAL FUNCTION%WIKIPATHWAYS_20250310%WP4222%HOMO SAPIENS	56	44		
RAS SIGNALING%WIKIPATHWAYS_20250310%WP4223%HOMO SAPIENS	185	163		
PURINE METABOLISM AND RELATED DISORDERS%WIKIPATHWAYS_20250310%WP4224%HOMO SAPIENS	23	20		
PYRIMIDINE METABOLISM AND RELATED DISEASES%WIKIPATHWAYS_20250310%WP4225%HOMO SAPIENS	20	19		
VITAMIN B6 DEPENDENT AND RESPONSIVE DISORDERS%WIKIPATHWAYS_20250310%WP4228%HOMO SAPIENS	7	7		
ACRYLAMIDE BIOTRANSFORMATION AND EXPOSURE BIOMARKERS%WIKIPATHWAYS_20250310%WP4233%HOMO SAPIENS	1		Rejected!	
KREBS CYCLE DISORDERS%WIKIPATHWAYS_20250310%WP4236%HOMO SAPIENS	13	13		
FLAVAN 3 OL METABOLIC PATHWAY%WIKIPATHWAYS_20250310%WP4238%HOMO SAPIENS	1		Rejected!	
EPITHELIAL TO MESENCHYMAL TRANSITION IN COLORECTAL CANCER%WIKIPATHWAYS_20250310%WP4239%HOMO SAPIENS	162	141		
REGULATION OF SISTER CHROMATID SEPARATION AT THE METAPHASE ANAPHASE TRANSITION%WIKIPATHWAYS_20250310%WP4240%HOMO SAPIENS	14	14		
TYPE 2 PAPILLARY RENAL CELL CARCINOMA%WIKIPATHWAYS_20250310%WP4241%HOMO SAPIENS	34	32		
HEDGEHOG SIGNALING%WIKIPATHWAYS_20250310%WP4249%HOMO SAPIENS	43	41		
NON SMALL CELL LUNG CANCER%WIKIPATHWAYS_20250310%WP4255%HOMO SAPIENS	72	68		
LNCRNA IN CANONICAL WNT SIGNALING AND COLORECTAL CANCER%WIKIPATHWAYS_20250310%WP4258%HOMO SAPIENS	98	80		
DISORDERS OF FOLATE METABOLISM AND TRANSPORT%WIKIPATHWAYS_20250310%WP4259%HOMO SAPIENS	19	19		
BREAST CANCER PATHWAY%WIKIPATHWAYS_20250310%WP4262%HOMO SAPIENS	155	131		
PANCREATIC ADENOCARCINOMA PATHWAY%WIKIPATHWAYS_20250310%WP4263%HOMO SAPIENS	89	87		
ETHANOL METABOLISM PRODUCTION OF ROS BY CYP2E1%WIKIPATHWAYS_20250310%WP4269%HOMO SAPIENS	9	9		
VITAMIN B12 DISORDERS%WIKIPATHWAYS_20250310%WP4271%HOMO SAPIENS	14	11		
WNT SIGNALING%WIKIPATHWAYS_20250310%WP428%HOMO SAPIENS	114	97		
ULTRACONSERVED REGION 339 MODULATION OF TUMOR SUPPRESSOR MICRORNAS IN CANCER%WIKIPATHWAYS_20250310%WP4284%HOMO SAPIENS	2		Rejected!	
MTHFR DEFICIENCY%WIKIPATHWAYS_20250310%WP4288%HOMO SAPIENS	24	22		
METABOLIC REPROGRAMMING IN COLON CANCER%WIKIPATHWAYS_20250310%WP4290%HOMO SAPIENS	42	42		
METHIONINE METABOLISM LEADING TO SULFUR AMINO ACIDS AND RELATED DISORDERS%WIKIPATHWAYS_20250310%WP4292%HOMO SAPIENS	13	12		
THIAMINE METABOLIC PATHWAYS%WIKIPATHWAYS_20250310%WP4297%HOMO SAPIENS	9	9		
ACUTE VIRAL MYOCARDITIS%WIKIPATHWAYS_20250310%WP4298%HOMO SAPIENS	85	74		
LAMIN A PROCESSING PATHWAY%WIKIPATHWAYS_20250310%WP4299%HOMO SAPIENS	3		Rejected!	
OXIDATION BY CYTOCHROME P450%WIKIPATHWAYS_20250310%WP43%HOMO SAPIENS	62	40		
STATIN INHIBITION OF CHOLESTEROL PRODUCTION%WIKIPATHWAYS_20250310%WP430%HOMO SAPIENS	31	21		
EXTRACELLULAR VESICLES IN THE CROSSTALK OF CARDIAC CELLS%WIKIPATHWAYS_20250310%WP4300%HOMO SAPIENS	21	17		
INHIBITION OF EXOSOME BIOGENESIS AND SECRETION BY MANUMYCIN A IN CRPC CELLS%WIKIPATHWAYS_20250310%WP4301%HOMO SAPIENS	18	18		
OLIGODENDROCYTE SPECIFICATION AND DIFFERENTIATION LEADING TO MYELIN COMPONENTS FOR CNS%WIKIPATHWAYS_20250310%WP4304%HOMO SAPIENS	31	19		
RETT SYNDROME%WIKIPATHWAYS_20250310%WP4312%HOMO SAPIENS	48	41		
FERROPTOSIS%WIKIPATHWAYS_20250310%WP4313%HOMO SAPIENS	66	60		
MALATE ASPARTATE SHUTTLE%WIKIPATHWAYS_20250310%WP4315%HOMO SAPIENS	4		Rejected!	
MIRNA DEGRADING ENZYMES%WIKIPATHWAYS_20250310%WP4316%HOMO SAPIENS	3		Rejected!	
MITOCHONDRIAL FATTY ACID SYNTHESIS PATHWAY%WIKIPATHWAYS_20250310%WP4317%HOMO SAPIENS	6	6		
MITOCHONDRIAL FISSION AND FUSION%WIKIPATHWAYS_20250310%WP4318%HOMO SAPIENS	13	13		
EFFECT OF PROGERIN ON GENES INVOLVED IN PROGERIA%WIKIPATHWAYS_20250310%WP4320%HOMO SAPIENS	37	24		
THERMOGENESIS%WIKIPATHWAYS_20250310%WP4321%HOMO SAPIENS	108	99		
MITOCHONDRIAL COMPLEX I ASSEMBLY MODEL OXPHOS SYSTEM%WIKIPATHWAYS_20250310%WP4324%HOMO SAPIENS	56	56		
MIRNA ROLE IN IMMUNE RESPONSE IN SEPSIS%WIKIPATHWAYS_20250310%WP4329%HOMO SAPIENS	64	36		
NEOVASCULARIZATION PROCESSES%WIKIPATHWAYS_20250310%WP4331%HOMO SAPIENS	37	37		
NCRNAS IN WNT SIGNALING IN HEPATOCELLULAR CARCINOMA%WIKIPATHWAYS_20250310%WP4336%HOMO SAPIENS	89	70		
NCRNAS INVOLVED IN STAT3 SIGNALING IN HEPATOCELLULAR CARCINOMA%WIKIPATHWAYS_20250310%WP4337%HOMO SAPIENS	17	13		
NON GENOMIC ACTIONS OF 1 25 DIHYDROXYVITAMIN D3%WIKIPATHWAYS_20250310%WP4341%HOMO SAPIENS	76	67		
VITAMINS A AND D ACTION MECHANISMS%WIKIPATHWAYS_20250310%WP4342%HOMO SAPIENS	3		Rejected!	
CILIARY LANDSCAPE%WIKIPATHWAYS_20250310%WP4352%HOMO SAPIENS	216	209		
NRF2 ARE REGULATION%WIKIPATHWAYS_20250310%WP4357%HOMO SAPIENS	23	22		
EGF EGFR SIGNALING%WIKIPATHWAYS_20250310%WP437%HOMO SAPIENS	159	157		
NON HOMOLOGOUS END JOINING%WIKIPATHWAYS_20250310%WP438%HOMO SAPIENS	10	10		
BILE ACID SYNTHESIS AND ENTEROHEPATIC CIRCULATION %WIKIPATHWAYS_20250310%WP4389%HOMO SAPIENS	12	7		
NONALCOHOLIC FATTY LIVER DISEASE%WIKIPATHWAYS_20250310%WP4396%HOMO SAPIENS	154	146		
MSMP EXPRESSION REGULATION IN CANCER CELLS AND ITS PRO ANGIOGENIC ROLE IN OVARIAN TUMORS%WIKIPATHWAYS_20250310%WP4397%HOMO SAPIENS	3		Rejected!	
MICRORNA NETWORK ASSOCIATED WITH CHRONIC LYMPHOCYTIC LEUKEMIA%WIKIPATHWAYS_20250310%WP4399%HOMO SAPIENS	7		Rejected!	
FABP4 IN OVARIAN CANCER%WIKIPATHWAYS_20250310%WP4400%HOMO SAPIENS	1		Rejected!	
PLATELET MEDIATED INTERACTIONS WITH VASCULAR AND CIRCULATING CELLS%WIKIPATHWAYS_20250310%WP4462%HOMO SAPIENS	17	16		
STEROIDOGENIC PATHWAY%WIKIPATHWAYS_20250310%WP4463%HOMO SAPIENS	6		Rejected!	
LTF DANGER SIGNAL RESPONSE PATHWAY%WIKIPATHWAYS_20250310%WP4478%HOMO SAPIENS	19	14		
SUPPRESSION OF HMGB1 MEDIATED INFLAMMATION BY THBD%WIKIPATHWAYS_20250310%WP4479%HOMO SAPIENS	9	9		
ALTERED GLYCOSYLATION OF MUC1 IN TUMOR MICROENVIRONMENT%WIKIPATHWAYS_20250310%WP4480%HOMO SAPIENS	9	8		
RESISTIN AS A REGULATOR OF INFLAMMATION%WIKIPATHWAYS_20250310%WP4481%HOMO SAPIENS	33	29		
VITAMIN D IN INFLAMMATORY DISEASES%WIKIPATHWAYS_20250310%WP4482%HOMO SAPIENS	22	21		
RELATIONSHIP BETWEEN INFLAMMATION COX 2 AND EGFR%WIKIPATHWAYS_20250310%WP4483%HOMO SAPIENS	25	23		
CONTROL OF IMMUNE TOLERANCE BY VASOACTIVE INTESTINAL PEPTIDE%WIKIPATHWAYS_20250310%WP4484%HOMO SAPIENS	13	6		
CELLS AND MOLECULES INVOLVED IN LOCAL ACUTE INFLAMMATORY RESPONSE %WIKIPATHWAYS_20250310%WP4493%HOMO SAPIENS	17	15		
SELECTIVE EXPRESSION OF CHEMOKINE RECEPTORS DURING T CELL POLARIZATION%WIKIPATHWAYS_20250310%WP4494%HOMO SAPIENS	29	21		
IL10 ANTI INFLAMMATORY SIGNALING%WIKIPATHWAYS_20250310%WP4495%HOMO SAPIENS	12	9		
SIGNAL TRANSDUCTION THROUGH IL1R%WIKIPATHWAYS_20250310%WP4496%HOMO SAPIENS	33	29		
G1 TO S CELL CYCLE CONTROL%WIKIPATHWAYS_20250310%WP45%HOMO SAPIENS	64	61		
CYSTEINE AND METHIONINE CATABOLISM%WIKIPATHWAYS_20250310%WP4504%HOMO SAPIENS	16	16		
TYROSINE METABOLISM AND RELATED DISORDERS%WIKIPATHWAYS_20250310%WP4506%HOMO SAPIENS	5		Rejected!	
MOLYBDENUM COFACTOR MOCO BIOSYNTHESIS%WIKIPATHWAYS_20250310%WP4507%HOMO SAPIENS	7	6		
GAMMA GLUTAMYL CYCLE FOR THE BIOSYNTHESIS AND DEGRADATION OF GLUTATHIONE INCLUDING DISEASES%WIKIPATHWAYS_20250310%WP4518%HOMO SAPIENS	6	6		
CEREBRAL ORGANIC ACIDURIAS INCLUDING DISEASES%WIKIPATHWAYS_20250310%WP4519%HOMO SAPIENS	8	8		
GLYCOSYLATION AND RELATED CONGENITAL DEFECTS%WIKIPATHWAYS_20250310%WP4521%HOMO SAPIENS	25	25		
METABOLIC PATHWAY OF LDL HDL AND TG INCLUDING DISEASES%WIKIPATHWAYS_20250310%WP4522%HOMO SAPIENS	17	13		
CLASSICAL PATHWAY OF STEROIDOGENESIS WITH GLUCOCORTICOID AND MINERALOCORTICOID METABOLISM%WIKIPATHWAYS_20250310%WP4523%HOMO SAPIENS	16	10		
ALTERNATIVE PATHWAY OF FETAL ANDROGEN SYNTHESIS%WIKIPATHWAYS_20250310%WP4524%HOMO SAPIENS	11	8		
INFLAMMATORY RESPONSE PATHWAY%WIKIPATHWAYS_20250310%WP453%HOMO SAPIENS	30	24		
INTRAFLAGELLAR TRANSPORT PROTEINS BINDING TO DYNEIN%WIKIPATHWAYS_20250310%WP4532%HOMO SAPIENS	27	26		
TRANSCRIPTION CO FACTORS SKI AND SKIL PROTEIN PARTNERS%WIKIPATHWAYS_20250310%WP4533%HOMO SAPIENS	18	18		
MECHANOREGULATION AND PATHOLOGY OF YAP TAZ VIA HIPPO AND NON HIPPO MECHANISMS%WIKIPATHWAYS_20250310%WP4534%HOMO SAPIENS	47	46		
ENVELOPE PROTEINS AND THEIR POTENTIAL ROLES IN EDMD PHYSIOPATHOLOGY%WIKIPATHWAYS_20250310%WP4535%HOMO SAPIENS	46	44		
GENES RELATED TO PRIMARY CILIUM DEVELOPMENT BASED ON CRISPR %WIKIPATHWAYS_20250310%WP4536%HOMO SAPIENS	104	101		
HIPPO YAP SIGNALING%WIKIPATHWAYS_20250310%WP4537%HOMO SAPIENS	22	22		
REGULATORY CIRCUITS OF STAT3 SIGNALING%WIKIPATHWAYS_20250310%WP4538%HOMO SAPIENS	78	71		
SYNAPTIC SIGNALING ASSOCIATED WITH AUTISM SPECTRUM DISORDER%WIKIPATHWAYS_20250310%WP4539%HOMO SAPIENS	51	46		
HIPPO SIGNALING REGULATION%WIKIPATHWAYS_20250310%WP4540%HOMO SAPIENS	98	86		
HIPPO MERLIN SIGNALING DYSREGULATION%WIKIPATHWAYS_20250310%WP4541%HOMO SAPIENS	121	107		
LEUKOCYTE INTRINSIC HIPPO PATHWAY FUNCTIONS%WIKIPATHWAYS_20250310%WP4542%HOMO SAPIENS	35	33		
OXYSTEROLS DERIVED FROM CHOLESTEROL%WIKIPATHWAYS_20250310%WP4545%HOMO SAPIENS	51	39		
FRAGILE X SYNDROME%WIKIPATHWAYS_20250310%WP4549%HOMO SAPIENS	122	109		
GPCRS CLASS A RHODOPSIN LIKE%WIKIPATHWAYS_20250310%WP455%HOMO SAPIENS	260	111		
FBXL10 ENHANCEMENT OF MAP ERK SIGNALING IN DIFFUSE LARGE B CELL LYMPHOMA%WIKIPATHWAYS_20250310%WP4553%HOMO SAPIENS	33	19		
INTERFERON MEDIATED SIGNALING%WIKIPATHWAYS_20250310%WP4558%HOMO SAPIENS	37	15		
INTERACTIONS BETWEEN IMMUNE CELLS AND MICRORNAS IN TUMOR MICROENVIRONMENT%WIKIPATHWAYS_20250310%WP4559%HOMO SAPIENS	47	28		
MFAP5 EFFECT ON PERMEABILITY AND MOTILITY OF ENDOTHELIAL CELLS VIA CYTOSKELETON REARRANGEMENT%WIKIPATHWAYS_20250310%WP4560%HOMO SAPIENS	18	17		
CANONICAL NF KB PATHWAY%WIKIPATHWAYS_20250310%WP4562%HOMO SAPIENS	8	8		
NEURAL CREST CELL MIGRATION DURING DEVELOPMENT%WIKIPATHWAYS_20250310%WP4564%HOMO SAPIENS	40	36		
NEURAL CREST CELL MIGRATION IN CANCER%WIKIPATHWAYS_20250310%WP4565%HOMO SAPIENS	43	39		
TRANSLATION INHIBITORS IN CHRONICALLY ACTIVATED PDGFRA CELLS%WIKIPATHWAYS_20250310%WP4566%HOMO SAPIENS	46	46		
UREA CYCLE AND RELATED DISEASES%WIKIPATHWAYS_20250310%WP4571%HOMO SAPIENS	9	7		
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION NBIA SUBTYPES PATHWAY%WIKIPATHWAYS_20250310%WP4577%HOMO SAPIENS	44	44		
CANCER IMMUNOTHERAPY BY CTLA4 BLOCKADE%WIKIPATHWAYS_20250310%WP4582%HOMO SAPIENS	14	13		
BIOMARKERS FOR UREA CYCLE DISORDERS%WIKIPATHWAYS_20250310%WP4583%HOMO SAPIENS	12	10		
BIOMARKERS FOR PYRIMIDINE METABOLISM DISORDERS%WIKIPATHWAYS_20250310%WP4584%HOMO SAPIENS	15	15		
CANCER IMMUNOTHERAPY BY PD 1 BLOCKADE%WIKIPATHWAYS_20250310%WP4585%HOMO SAPIENS	23	22		
METABOLISM OF ALPHA LINOLENIC ACID%WIKIPATHWAYS_20250310%WP4586%HOMO SAPIENS	6	5		
MAJOR RECEPTORS TARGETED BY EPINEPHRINE AND NOREPINEPHRINE%WIKIPATHWAYS_20250310%WP4589%HOMO SAPIENS	16	13		
UREA CYCLE AND ASSOCIATED PATHWAYS%WIKIPATHWAYS_20250310%WP4595%HOMO SAPIENS	24	22		
AEROBIC GLYCOLYSIS AUGMENTED%WIKIPATHWAYS_20250310%WP4628%HOMO SAPIENS	13	13		
MEASLES VIRUS INFECTION%WIKIPATHWAYS_20250310%WP4630%HOMO SAPIENS	136	116		
TRYPTOPHAN METABOLISM%WIKIPATHWAYS_20250310%WP465%HOMO SAPIENS	33	30		
CYTOSOLIC DNA SENSING PATHWAY%WIKIPATHWAYS_20250310%WP4655%HOMO SAPIENS	74	58		
JOUBERT SYNDROME%WIKIPATHWAYS_20250310%WP4656%HOMO SAPIENS	76	73		
22Q11 2 COPY NUMBER VARIATION SYNDROME%WIKIPATHWAYS_20250310%WP4657%HOMO SAPIENS	125	100		
SMALL CELL LUNG CANCER%WIKIPATHWAYS_20250310%WP4658%HOMO SAPIENS	95	93		
GASTRIN SIGNALING%WIKIPATHWAYS_20250310%WP4659%HOMO SAPIENS	115	108		
DNA REPLICATION%WIKIPATHWAYS_20250310%WP466%HOMO SAPIENS	42	40		
AMINO ACID METABOLISM PATHWAY EXCERPT HISTIDINE CATABOLISM EXTENSION%WIKIPATHWAYS_20250310%WP4661%HOMO SAPIENS	6		Rejected!	
HEPATITIS B INFECTION%WIKIPATHWAYS_20250310%WP4666%HOMO SAPIENS	152	134		
MALE INFERTILITY%WIKIPATHWAYS_20250310%WP4673%HOMO SAPIENS	145	108		
HEAD AND NECK SQUAMOUS CELL CARCINOMA%WIKIPATHWAYS_20250310%WP4674%HOMO SAPIENS	74	70		
MELANOMA%WIKIPATHWAYS_20250310%WP4685%HOMO SAPIENS	68	65		
LEUCINE ISOLEUCINE AND VALINE METABOLISM%WIKIPATHWAYS_20250310%WP4686%HOMO SAPIENS	24	24		
SERINE METABOLISM%WIKIPATHWAYS_20250310%WP4688%HOMO SAPIENS	8	8		
VITAMIN D SENSITIVE CALCIUM SIGNALING IN DEPRESSION%WIKIPATHWAYS_20250310%WP4698%HOMO SAPIENS	37	27		
HEDGEHOG SIGNALING%WIKIPATHWAYS_20250310%WP47%HOMO SAPIENS	16	16		
PATHWAYS OF NUCLEIC ACID METABOLISM AND INNATE IMMUNE SENSING%WIKIPATHWAYS_20250310%WP4705%HOMO SAPIENS	16	15		
ASPIRIN AND MIRNAS%WIKIPATHWAYS_20250310%WP4707%HOMO SAPIENS	10	9		
CHOLESTEROL METABOLISM WITH BLOCH AND KANDUTSCH RUSSELL PATHWAYS%WIKIPATHWAYS_20250310%WP4718%HOMO SAPIENS	47	45		
EICOSANOID METABOLISM VIA CYCLOOXYGENASES COX %WIKIPATHWAYS_20250310%WP4719%HOMO SAPIENS	31	30		
EICOSANOID METABOLISM VIA CYTOCHROME P450 MONOOXYGENASES PATHWAY%WIKIPATHWAYS_20250310%WP4720%HOMO SAPIENS	9	8		
EICOSANOID METABOLISM VIA LIPOOXYGENASES LOX %WIKIPATHWAYS_20250310%WP4721%HOMO SAPIENS	29	26		
GLYCEROLIPIDS AND GLYCEROPHOSPHOLIPIDS%WIKIPATHWAYS_20250310%WP4722%HOMO SAPIENS	22	21		
OMEGA 3 OMEGA 6 FATTY ACID SYNTHESIS%WIKIPATHWAYS_20250310%WP4723%HOMO SAPIENS	15	13		
OMEGA 9 FATTY ACID SYNTHESIS%WIKIPATHWAYS_20250310%WP4724%HOMO SAPIENS	14	12		
SPHINGOLIPID METABOLISM OVERVIEW%WIKIPATHWAYS_20250310%WP4725%HOMO SAPIENS	27	25		
SPHINGOLIPID METABOLISM INTEGRATED PATHWAY%WIKIPATHWAYS_20250310%WP4726%HOMO SAPIENS	26	24		
ENDOCHONDRAL OSSIFICATION%WIKIPATHWAYS_20250310%WP474%HOMO SAPIENS	63	55		
KETOGENESIS AND KETOLYSIS%WIKIPATHWAYS_20250310%WP4742%HOMO SAPIENS	8	8		
THYROID HORMONES PRODUCTION AND PERIPHERAL DOWNSTREAM SIGNALING EFFECTS%WIKIPATHWAYS_20250310%WP4746%HOMO SAPIENS	93	76		
NETRIN UNC5B SIGNALING%WIKIPATHWAYS_20250310%WP4747%HOMO SAPIENS	52	47		
HIPK2 IN KIDNEY FIBROSIS%WIKIPATHWAYS_20250310%WP4751%HOMO SAPIENS	2		Rejected!	
BASE EXCISION REPAIR%WIKIPATHWAYS_20250310%WP4752%HOMO SAPIENS	31	30		
NUCLEOTIDE EXCISION REPAIR%WIKIPATHWAYS_20250310%WP4753%HOMO SAPIENS	44	44		
IL18 SIGNALING%WIKIPATHWAYS_20250310%WP4754%HOMO SAPIENS	56	51		
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM RAAS %WIKIPATHWAYS_20250310%WP4756%HOMO SAPIENS	44	37		
NEPHROTIC SYNDROME%WIKIPATHWAYS_20250310%WP4758%HOMO SAPIENS	45	44		
PKC GAMMA CALCIUM SIGNALING IN ATAXIA%WIKIPATHWAYS_20250310%WP4760%HOMO SAPIENS	22	16		
FGFR3 SIGNALING IN CHONDROCYTE PROLIFERATION AND TERMINAL DIFFERENTIATION%WIKIPATHWAYS_20250310%WP4767%HOMO SAPIENS	27	25		
CYTOPLASMIC RIBOSOMAL PROTEINS%WIKIPATHWAYS_20250310%WP477%HOMO SAPIENS	88	87		
PROTEOGLYCAN BIOSYNTHESIS%WIKIPATHWAYS_20250310%WP4784%HOMO SAPIENS	18	18		
SOMITOGENESIS IN THE CONTEXT OF SPONDYLOCOSTAL DYSOSTOSIS%WIKIPATHWAYS_20250310%WP4785%HOMO SAPIENS	9	5		
TYPE I COLLAGEN SYNTHESIS IN THE CONTEXT OF OSTEOGENESIS IMPERFECTA%WIKIPATHWAYS_20250310%WP4786%HOMO SAPIENS	33	29		
OSTEOBLAST DIFFERENTIATION AND RELATED DISEASES%WIKIPATHWAYS_20250310%WP4787%HOMO SAPIENS	119	100		
AUTOSOMAL RECESSIVE OSTEOPETROSIS PATHWAYS%WIKIPATHWAYS_20250310%WP4788%HOMO SAPIENS	11	10		
MULTIPLE EPIPHYSEAL DYSPLASIA AND PSEUDOACHONDROPLASIA GENES%WIKIPATHWAYS_20250310%WP4789%HOMO SAPIENS	6		Rejected!	
FGF23 SIGNALING IN HYPOPHOSPHATEMIC RICKETS AND RELATED DISORDERS%WIKIPATHWAYS_20250310%WP4790%HOMO SAPIENS	23	18		
PURINE METABOLISM%WIKIPATHWAYS_20250310%WP4792%HOMO SAPIENS	13	11		
DOWNREGULATION OF ACE2 BY SARS COV 2 SPIKE PROTEIN%WIKIPATHWAYS_20250310%WP4799%HOMO SAPIENS	4		Rejected!	
CILIOPATHIES%WIKIPATHWAYS_20250310%WP4803%HOMO SAPIENS	184	170		
CHOLESTEROL BIOSYNTHESIS WITH SKELETAL DYSPLASIAS%WIKIPATHWAYS_20250310%WP4804%HOMO SAPIENS	7	7		
EGFR TYROSINE KINASE INHIBITOR RESISTANCE%WIKIPATHWAYS_20250310%WP4806%HOMO SAPIENS	84	81		
ENDOCHONDRAL OSSIFICATION WITH SKELETAL DYSPLASIAS%WIKIPATHWAYS_20250310%WP4808%HOMO SAPIENS	63	55		
INSULIN SIGNALING%WIKIPATHWAYS_20250310%WP481%HOMO SAPIENS	160	158		
SOMATIC SEX DETERMINATION%WIKIPATHWAYS_20250310%WP4814%HOMO SAPIENS	16	9		
GLYCOSAMINOGLYCAN DEGRADATION%WIKIPATHWAYS_20250310%WP4815%HOMO SAPIENS	17	16		
TGF BETA RECEPTOR SIGNALING IN SKELETAL DYSPLASIAS%WIKIPATHWAYS_20250310%WP4816%HOMO SAPIENS	59	54		
CONVERSION OF ANGIOTENSINOGEN TO ANGIOTENSIN II %WIKIPATHWAYS_20250310%WP4818%HOMO SAPIENS	5		Rejected!	
GENES CONTROLLING NEPHROGENESIS%WIKIPATHWAYS_20250310%WP4823%HOMO SAPIENS	46	43		
MBDNF AND PROBDNF REGULATION OF GABA NEUROTRANSMISSION%WIKIPATHWAYS_20250310%WP4829%HOMO SAPIENS	38	27		
GDNF RET SIGNALING AXIS%WIKIPATHWAYS_20250310%WP4830%HOMO SAPIENS	31	26		
REGUCALCIN IN PROXIMAL TUBULE EPITHELIAL KIDNEY CELLS%WIKIPATHWAYS_20250310%WP4838%HOMO SAPIENS	32	29		
MAMMALIAN DISORDER OF SEXUAL DEVELOPMENT%WIKIPATHWAYS_20250310%WP4842%HOMO SAPIENS	25	16		
INFLUENCE OF LAMINOPATHIES ON WNT SIGNALING%WIKIPATHWAYS_20250310%WP4844%HOMO SAPIENS	37	31		
SARS COV 2 AND COVID 19 PATHWAY%WIKIPATHWAYS_20250310%WP4846%HOMO SAPIENS	11	10		
LINOLEIC ACID METABOLISM AFFECTED BY SARS COV 2%WIKIPATHWAYS_20250310%WP4853%HOMO SAPIENS	6	5		
INTRACELLULAR TRAFFICKING PROTEINS INVOLVED IN CMT NEUROPATHY%WIKIPATHWAYS_20250310%WP4856%HOMO SAPIENS	27	26		
HIJACK OF UBIQUITINATION BY SARS COV 2%WIKIPATHWAYS_20250310%WP4860%HOMO SAPIENS	8	8		
ENDOPLASMIC RETICULUM STRESS RESPONSE IN CORONAVIRUS INFECTION%WIKIPATHWAYS_20250310%WP4861%HOMO SAPIENS	46	44		
HOST PATHOGEN INTERACTION OF HUMAN CORONAVIRUSES AUTOPHAGY%WIKIPATHWAYS_20250310%WP4863%HOMO SAPIENS	19	19		
HOST PATHOGEN INTERACTION OF HUMAN CORONAVIRUSES APOPTOSIS%WIKIPATHWAYS_20250310%WP4864%HOMO SAPIENS	22	21		
TYPE I INTERFERON INDUCTION AND SIGNALING DURING SARS COV 2 INFECTION%WIKIPATHWAYS_20250310%WP4868%HOMO SAPIENS	32	30		
KISSPEPTIN KISSPEPTIN RECEPTOR SYSTEM IN THE OVARY%WIKIPATHWAYS_20250310%WP4871%HOMO SAPIENS	39	30		
MAP3K1 ROLE IN PROMOTING AND BLOCKING GONADAL DETERMINATION%WIKIPATHWAYS_20250310%WP4872%HOMO SAPIENS	17	15		
PEROXIREDOXIN 2 INDUCED OVARIAN FAILURE%WIKIPATHWAYS_20250310%WP4873%HOMO SAPIENS	8	6		
CAMKK2 PATHWAY%WIKIPATHWAYS_20250310%WP4874%HOMO SAPIENS	110	100		
DISRUPTION OF POSTSYNAPTIC SIGNALING BY CNV%WIKIPATHWAYS_20250310%WP4875%HOMO SAPIENS	33	27		
ACTIVATION OF NLRP3 INFLAMMASOME BY SARS COV 2%WIKIPATHWAYS_20250310%WP4876%HOMO SAPIENS	7	7		
HOST PATHOGEN INTERACTION OF HUMAN CORONAVIRUSES MAPK SIGNALING%WIKIPATHWAYS_20250310%WP4877%HOMO SAPIENS	36	36		
OVERLAP BETWEEN SIGNAL TRANSDUCTION PATHWAYS CONTRIBUTING TO LMNA LAMINOPATHIES%WIKIPATHWAYS_20250310%WP4879%HOMO SAPIENS	57	51		
HOST PATHOGEN INTERACTION OF HUMAN CORONAVIRUSES INTERFERON INDUCTION%WIKIPATHWAYS_20250310%WP4880%HOMO SAPIENS	33	33		
SARS COV 2 AND ACE2 RECEPTOR MOLECULAR MECHANISMS%WIKIPATHWAYS_20250310%WP4883%HOMO SAPIENS	8	6		
PATHOGENESIS OF SARS COV 2 MEDIATED BY NSP9 NSP10 COMPLEX%WIKIPATHWAYS_20250310%WP4884%HOMO SAPIENS	21	17		
COVID 19 ADVERSE OUTCOME PATHWAY%WIKIPATHWAYS_20250310%WP4891%HOMO SAPIENS	16	11		
IL2 SIGNALING%WIKIPATHWAYS_20250310%WP49%HOMO SAPIENS	37	36		
PURINERGIC SIGNALING%WIKIPATHWAYS_20250310%WP4900%HOMO SAPIENS	34	27		
LDLRAD4 AND WHAT WE KNOW ABOUT IT%WIKIPATHWAYS_20250310%WP4904%HOMO SAPIENS	7	7		
1Q21 1 COPY NUMBER VARIATION SYNDROME%WIKIPATHWAYS_20250310%WP4905%HOMO SAPIENS	27	25		
3Q29 COPY NUMBER VARIATION SYNDROME%WIKIPATHWAYS_20250310%WP4906%HOMO SAPIENS	64	58		
SARS CORONAVIRUS AND INNATE IMMUNITY%WIKIPATHWAYS_20250310%WP4912%HOMO SAPIENS	31	17		
PROXIMAL TUBULE TRANSPORT%WIKIPATHWAYS_20250310%WP4917%HOMO SAPIENS	57	56		
CELLULAR PROTEOSTASIS%WIKIPATHWAYS_20250310%WP4918%HOMO SAPIENS	6	6		
NEUROINFLAMMATION%WIKIPATHWAYS_20250310%WP4919%HOMO SAPIENS	13	13		
MITOCHONDRIAL COMPLEX II ASSEMBLY%WIKIPATHWAYS_20250310%WP4920%HOMO SAPIENS	8	8		
MITOCHONDRIAL COMPLEX III ASSEMBLY%WIKIPATHWAYS_20250310%WP4921%HOMO SAPIENS	16	16		
MITOCHONDRIAL COMPLEX IV ASSEMBLY%WIKIPATHWAYS_20250310%WP4922%HOMO SAPIENS	34	34		
AUTOPHAGY%WIKIPATHWAYS_20250310%WP4923%HOMO SAPIENS	30	30		
UNFOLDED PROTEIN RESPONSE%WIKIPATHWAYS_20250310%WP4925%HOMO SAPIENS	23	23		
COVID 19 THROMBOSIS AND ANTICOAGULATION%WIKIPATHWAYS_20250310%WP4927%HOMO SAPIENS	7		Rejected!	
MAPK PATHWAY IN CONGENITAL THYROID CANCER%WIKIPATHWAYS_20250310%WP4928%HOMO SAPIENS	16	15		
DIRECT REVERSAL REPAIR%WIKIPATHWAYS_20250310%WP4931%HOMO SAPIENS	3		Rejected!	
7Q11 23 COPY NUMBER VARIATION SYNDROME%WIKIPATHWAYS_20250310%WP4932%HOMO SAPIENS	107	101		
PERTURBATIONS TO HOST CELL AUTOPHAGY INDUCED BY SARS COV 2 PROTEINS%WIKIPATHWAYS_20250310%WP4936%HOMO SAPIENS	44	43		
15Q11 2 COPY NUMBER VARIATION SYNDROME%WIKIPATHWAYS_20250310%WP4940%HOMO SAPIENS	9	9		
GPR143 IN MELANOCYTES AND RETINAL PIGMENT EPITHELIUM CELLS%WIKIPATHWAYS_20250310%WP4941%HOMO SAPIENS	30	26		
15Q13 3 COPY NUMBER VARIATION SYNDROME%WIKIPATHWAYS_20250310%WP4942%HOMO SAPIENS	21	16		
DNA REPAIR PATHWAYS FULL NETWORK%WIKIPATHWAYS_20250310%WP4946%HOMO SAPIENS	121	118		
NITRIC OXIDE METABOLISM IN CYSTIC FIBROSIS%WIKIPATHWAYS_20250310%WP4947%HOMO SAPIENS	13	12		
16P11 2 PROXIMAL DELETION SYNDROME%WIKIPATHWAYS_20250310%WP4949%HOMO SAPIENS	76	68		
16P11 2 DISTAL DELETION SYNDROME%WIKIPATHWAYS_20250310%WP4950%HOMO SAPIENS	33	30		
STEROID BIOSYNTHESIS%WIKIPATHWAYS_20250310%WP496%HOMO SAPIENS	10	7		
STING PATHWAY IN KAWASAKI LIKE DISEASE AND COVID 19%WIKIPATHWAYS_20250310%WP4961%HOMO SAPIENS	21	20		
AIRWAY SMOOTH MUSCLE CELL CONTRACTION%WIKIPATHWAYS_20250310%WP4962%HOMO SAPIENS	16	14		
P53 TRANSCRIPTIONAL GENE NETWORK%WIKIPATHWAYS_20250310%WP4963%HOMO SAPIENS	97	85		
FLUOROACETIC ACID TOXICITY%WIKIPATHWAYS_20250310%WP4966%HOMO SAPIENS	6	6		
RAS AND BRADYKININ PATHWAYS IN COVID 19%WIKIPATHWAYS_20250310%WP4969%HOMO SAPIENS	29	26		
UREA CYCLE AND METABOLISM OF AMINO GROUPS%WIKIPATHWAYS_20250310%WP497%HOMO SAPIENS	21	19		
GALANIN RECEPTOR PATHWAY%WIKIPATHWAYS_20250310%WP4970%HOMO SAPIENS	16	12		
PHOSPHOINOSITIDES METABOLISM%WIKIPATHWAYS_20250310%WP4971%HOMO SAPIENS	49	47		
GLYCOGEN SYNTHESIS AND DEGRADATION%WIKIPATHWAYS_20250310%WP500%HOMO SAPIENS	40	39		
GPCRS CLASS C METABOTROPIC GLUTAMATE PHEROMONE%WIKIPATHWAYS_20250310%WP501%HOMO SAPIENS	15	7		
PROLINE AND HYDROXYPROLINE PATHWAYS%WIKIPATHWAYS_20250310%WP5026%HOMO SAPIENS	5	5		
NSP1 FROM SARS COV 2 INHIBITS TRANSLATION INITIATION IN THE HOST CELL%WIKIPATHWAYS_20250310%WP5027%HOMO SAPIENS	18	17		
GLYCINE METABOLISM INCLUDING IMDS%WIKIPATHWAYS_20250310%WP5028%HOMO SAPIENS	15	15		
AMINO ACID TRANSPORT DEFECTS IEMS %WIKIPATHWAYS_20250310%WP5029%HOMO SAPIENS	9	9		
ETHYLMALONIC ENCEPHALOPATHY%WIKIPATHWAYS_20250310%WP5030%HOMO SAPIENS	3		Rejected!	
BIOTIN METABOLISM INCLUDING IMDS%WIKIPATHWAYS_20250310%WP5031%HOMO SAPIENS	9	9		
GENES ASSOCIATED WITH THE DEVELOPMENT OF RHEUMATOID ARTHRITIS%WIKIPATHWAYS_20250310%WP5033%HOMO SAPIENS	18	17		
ANGIOTENSIN II RECEPTOR TYPE 1 PATHWAY%WIKIPATHWAYS_20250310%WP5036%HOMO SAPIENS	28	27		
RIBOFLAVIN AND COQ DISORDERS%WIKIPATHWAYS_20250310%WP5037%HOMO SAPIENS	14	13		
MITOCHONDRIAL IMMUNE RESPONSE TO SARS COV 2%WIKIPATHWAYS_20250310%WP5038%HOMO SAPIENS	34	31		
SARS COV 2 INNATE IMMUNITY EVASION AND CELL SPECIFIC IMMUNE RESPONSE%WIKIPATHWAYS_20250310%WP5039%HOMO SAPIENS	66	55		
PENTOSE PHOSPHATE PATHWAY IN SENESCENT CELLS%WIKIPATHWAYS_20250310%WP5043%HOMO SAPIENS	8	7		
KYNURENINE PATHWAY AND LINKS TO CELL SENESCENCE%WIKIPATHWAYS_20250310%WP5044%HOMO SAPIENS	24	22		
NAD METABOLISM IN ONCOGENE INDUCED SENESCENCE AND MITOCHONDRIAL DYSFUNCTION ASSOCIATED SENESCENCE%WIKIPATHWAYS_20250310%WP5046%HOMO SAPIENS	22	20		
GLYCOLYSIS IN SENESCENCE%WIKIPATHWAYS_20250310%WP5049%HOMO SAPIENS	11	11		
TCA CYCLE IN SENESCENCE%WIKIPATHWAYS_20250310%WP5050%HOMO SAPIENS	10	10		
NEPHROGENESIS%WIKIPATHWAYS_20250310%WP5052%HOMO SAPIENS	18	13		
DEVELOPMENT OF URETERIC DERIVED COLLECTING SYSTEM%WIKIPATHWAYS_20250310%WP5053%HOMO SAPIENS	48	45		
BURN WOUND HEALING%WIKIPATHWAYS_20250310%WP5055%HOMO SAPIENS	75	64		
FATTY ACID TRANSPORTERS%WIKIPATHWAYS_20250310%WP5061%HOMO SAPIENS	18	14		
FOXP3 IN COVID 19%WIKIPATHWAYS_20250310%WP5063%HOMO SAPIENS	15	12		
7 OXO C AND 7 BETA HC PATHWAYS%WIKIPATHWAYS_20250310%WP5064%HOMO SAPIENS	27	25		
SARS COV 2 ALTERING ANGIOGENESIS VIA NRP1%WIKIPATHWAYS_20250310%WP5065%HOMO SAPIENS	5	5		
FOXA2 PATHWAY%WIKIPATHWAYS_20250310%WP5066%HOMO SAPIENS	21	16		
MODULATORS OF TCR SIGNALING AND T CELL ACTIVATION%WIKIPATHWAYS_20250310%WP5072%HOMO SAPIENS	61	61		
KALLMANN SYNDROME%WIKIPATHWAYS_20250310%WP5074%HOMO SAPIENS	24	14		
SOLUBLE ACE2 MEDIATED CELL ENTRY OF SARS COV 2%WIKIPATHWAYS_20250310%WP5076%HOMO SAPIENS	4		Rejected!	
T CELL MODULATION AND DESMOPLASIA IN PANCREATIC CANCER%WIKIPATHWAYS_20250310%WP5078%HOMO SAPIENS	55	47		
NEUROINFLAMMATION AND GLUTAMATERGIC SIGNALING%WIKIPATHWAYS_20250310%WP5083%HOMO SAPIENS	140	111		
VASOPRESSIN REGULATED WATER REABSORPTION%WIKIPATHWAYS_20250310%WP5085%HOMO SAPIENS	44	41		
PLEURAL MESOTHELIOMA%WIKIPATHWAYS_20250310%WP5087%HOMO SAPIENS	439	381		
PROSTAGLANDIN SIGNALING%WIKIPATHWAYS_20250310%WP5088%HOMO SAPIENS	33	25		
KININ KALLIKREIN PATHWAY%WIKIPATHWAYS_20250310%WP5089%HOMO SAPIENS	7	6		
COMPLEMENT SYSTEM IN NEURONAL DEVELOPMENT AND PLASTICITY%WIKIPATHWAYS_20250310%WP5090%HOMO SAPIENS	107	97		
INTERACTIONS OF NATURAL KILLER CELLS IN PANCREATIC CANCER%WIKIPATHWAYS_20250310%WP5092%HOMO SAPIENS	28	23		
OPIOID RECEPTOR PATHWAYS%WIKIPATHWAYS_20250310%WP5093%HOMO SAPIENS	1		Rejected!	
OREXIN RECEPTOR PATHWAY%WIKIPATHWAYS_20250310%WP5094%HOMO SAPIENS	88	67		
OVERVIEW OF PROINFLAMMATORY AND PROFIBROTIC MEDIATORS%WIKIPATHWAYS_20250310%WP5095%HOMO SAPIENS	129	50		
CCL18 SIGNALING%WIKIPATHWAYS_20250310%WP5097%HOMO SAPIENS	6	5		
T CELL ACTIVATION SARS COV 2%WIKIPATHWAYS_20250310%WP5098%HOMO SAPIENS	88	77		
REGULATION OF ACTIN CYTOSKELETON%WIKIPATHWAYS_20250310%WP51%HOMO SAPIENS	150	131		
CONGENITAL GENERALIZED LIPODYSTROPHY%WIKIPATHWAYS_20250310%WP5101%HOMO SAPIENS	18	17		
FAMILIAL PARTIAL LIPODYSTROPHY%WIKIPATHWAYS_20250310%WP5102%HOMO SAPIENS	30	27		
PROGERIA ASSOCIATED LIPODYSTROPHY%WIKIPATHWAYS_20250310%WP5103%HOMO SAPIENS	22	18		
ACQUIRED PARTIAL LIPODYSTROPHY BARRAQUER SIMONS SYNDROME%WIKIPATHWAYS_20250310%WP5104%HOMO SAPIENS	10	10		
FAMILIAL HYPERLIPIDEMIA TYPE 1%WIKIPATHWAYS_20250310%WP5108%HOMO SAPIENS	18	13		
FAMILIAL HYPERLIPIDEMIA TYPE 2%WIKIPATHWAYS_20250310%WP5109%HOMO SAPIENS	16	11		
FAMILIAL HYPERLIPIDEMIA TYPE 3%WIKIPATHWAYS_20250310%WP5110%HOMO SAPIENS	13	10		
FAMILIAL HYPERLIPIDEMIA TYPE 4%WIKIPATHWAYS_20250310%WP5111%HOMO SAPIENS	22	15		
FAMILIAL HYPERLIPIDEMIA TYPE 5%WIKIPATHWAYS_20250310%WP5112%HOMO SAPIENS	15	11		
ANTIVIRAL AND ANTI INFLAMMATORY EFFECTS OF NRF2 ON SARS COV 2 PATHWAY%WIKIPATHWAYS_20250310%WP5113%HOMO SAPIENS	33	26		
NUCLEOTIDE EXCISION REPAIR IN XERODERMA PIGMENTOSUM %WIKIPATHWAYS_20250310%WP5114%HOMO SAPIENS	75	63		
NETWORK MAP OF SARS COV 2 SIGNALING%WIKIPATHWAYS_20250310%WP5115%HOMO SAPIENS	254	216		
SARS COV 2 B 1 1 7 VARIANT ANTAGONISES INNATE IMMUNE ACTIVATION%WIKIPATHWAYS_20250310%WP5116%HOMO SAPIENS	9	8		
COHESIN COMPLEX CORNELIA DE LANGE SYNDROME%WIKIPATHWAYS_20250310%WP5117%HOMO SAPIENS	34	32		
SMC1 SMC3 ROLE IN DNA DAMAGE CORNELIA DE LANGE SYNDROME%WIKIPATHWAYS_20250310%WP5118%HOMO SAPIENS	11	11		
NIPBL ROLE IN DNA DAMAGE CORNELIA DE LANGE SYNDROME%WIKIPATHWAYS_20250310%WP5119%HOMO SAPIENS	8	8		
INCLUSION BODY MYOSITIS%WIKIPATHWAYS_20250310%WP5120%HOMO SAPIENS	11	11		
SPHINGOLIPID METABOLISM IN SENESCENCE%WIKIPATHWAYS_20250310%WP5121%HOMO SAPIENS	28	27		
PROSTAGLANDIN AND LEUKOTRIENE METABOLISM IN SENESCENCE %WIKIPATHWAYS_20250310%WP5122%HOMO SAPIENS	31	29		
MITOCHONDRIAL FATTY ACID OXIDATION DISORDERS%WIKIPATHWAYS_20250310%WP5123%HOMO SAPIENS	19	19		
ALZHEIMER 39 S DISEASE%WIKIPATHWAYS_20250310%WP5124%HOMO SAPIENS	264	230		
TH17 CELL DIFFERENTIATION PATHWAY%WIKIPATHWAYS_20250310%WP5130%HOMO SAPIENS	70	59		
NON CLASSICAL ROLE OF VITAMIN D%WIKIPATHWAYS_20250310%WP5133%HOMO SAPIENS	8	7		
ALA OXYLIPIN METABOLISM%WIKIPATHWAYS_20250310%WP5136%HOMO SAPIENS	3		Rejected!	
LINOLEIC ACID OXYLIPIN METABOLISM%WIKIPATHWAYS_20250310%WP5137%HOMO SAPIENS	3		Rejected!	
CALCIUM MEDIATED T CELL APOPTOSIS INVOLVED IN INCLUSION BODY MYOSITIS%WIKIPATHWAYS_20250310%WP5142%HOMO SAPIENS	20	20		
GDNF SIGNALING%WIKIPATHWAYS_20250310%WP5143%HOMO SAPIENS	1		Rejected!	
NRP1 TRIGGERED SIGNALING IN PANCREATIC CANCER %WIKIPATHWAYS_20250310%WP5144%HOMO SAPIENS	53	53		
COVID 19 STRUCTURAL COVERAGE MAP%WIKIPATHWAYS_20250310%WP5145%HOMO SAPIENS	26	24		
LUNG PATHOLOGY OF COVID 19%WIKIPATHWAYS_20250310%WP5146%HOMO SAPIENS	20	18		
COMPLEMENT MEDIATED INFLAMMATION OF PULMONARY ALVEOLUS IN COVID 19 HYPOTHETICAL PATHWAY %WIKIPATHWAYS_20250310%WP5148%HOMO SAPIENS	12	10		
LIPID METABOLISM IN SENESCENT CELLS%WIKIPATHWAYS_20250310%WP5149%HOMO SAPIENS	20	13		
SPINA BIFIDA%WIKIPATHWAYS_20250310%WP5150%HOMO SAPIENS	12	12		
IRON SULFUR CLUSTER BIOGENESIS%WIKIPATHWAYS_20250310%WP5152%HOMO SAPIENS	15	15		
N GLYCAN BIOSYNTHESIS%WIKIPATHWAYS_20250310%WP5153%HOMO SAPIENS	57	54		
DOCOSAHEXAENOIC ACID OXYLIPIN METABOLISM%WIKIPATHWAYS_20250310%WP5154%HOMO SAPIENS	2		Rejected!	
ARACHIDONIC ACID AA ARA OXYLIPIN METABOLISM%WIKIPATHWAYS_20250310%WP5155%HOMO SAPIENS	4		Rejected!	
SARS COV 2 REPLICATION ORGANELLE FORMATION%WIKIPATHWAYS_20250310%WP5156%HOMO SAPIENS	1		Rejected!	
UROTENSIN II MEDIATED SIGNALING%WIKIPATHWAYS_20250310%WP5158%HOMO SAPIENS	69	63		
EXERCISE AND HYPERTROPHY IN SKELETAL MUSCLE%WIKIPATHWAYS_20250310%WP516%HOMO SAPIENS	20	17		
GLYOXYLATE METABOLISM%WIKIPATHWAYS_20250310%WP5166%HOMO SAPIENS	11	11		
HEMESYNTHESIS DEFECTS AND PORPHYRIAS%WIKIPATHWAYS_20250310%WP5169%HOMO SAPIENS	9	8		
LEUKOTRIENE METABOLIC PATHWAY%WIKIPATHWAYS_20250310%WP5171%HOMO SAPIENS	13	13		
IRON METABOLISM DISORDERS%WIKIPATHWAYS_20250310%WP5172%HOMO SAPIENS	17	14		
DISORDERS OF GALACTOSE METABOLISM %WIKIPATHWAYS_20250310%WP5173%HOMO SAPIENS	13	13		
ULCERATIVE COLITIS SIGNALING%WIKIPATHWAYS_20250310%WP5174%HOMO SAPIENS	18	13		
DISORDERS IN KETONE BODY SYNTHESIS%WIKIPATHWAYS_20250310%WP5175%HOMO SAPIENS	5	5		
DISORDERS OF BILE ACID SYNTHESIS AND BILIARY TRANSPORT%WIKIPATHWAYS_20250310%WP5176%HOMO SAPIENS	29	20		
DISORDERS OF FRUCTOSE METABOLISM%WIKIPATHWAYS_20250310%WP5178%HOMO SAPIENS	14	14		
BIOSYNTHESIS AND TURNOVER OF 1 DEOXY SPHINGOID BASES%WIKIPATHWAYS_20250310%WP5179%HOMO SAPIENS	8	8		
DYRK1A INVOLVEMENT REGARDING CELL PROLIFERATION IN BRAIN DEVELOPMENT%WIKIPATHWAYS_20250310%WP5180%HOMO SAPIENS	62	59		
ROLES OF CERAMIDES IN DEVELOPMENT OF INSULIN RESISTANCE%WIKIPATHWAYS_20250310%WP5181%HOMO SAPIENS	23	20		
PRO SURVIVAL SIGNALING OF NEUROPROTECTIN D1%WIKIPATHWAYS_20250310%WP5182%HOMO SAPIENS	15	15		
SARS COV 2 MITOCHONDRIAL CHRONIC OXIDATIVE STRESS AND ENDOTHELIAL DYSFUNCTION%WIKIPATHWAYS_20250310%WP5183%HOMO SAPIENS	26	24		
VITAMIN K METABOLISM AND ACTIVATION OF DEPENDENT PROTEINS%WIKIPATHWAYS_20250310%WP5186%HOMO SAPIENS	13	11		
MRNA VACCINE ACTIVATION OF DENDRITIC CELL AND INDUCTION OF IFN 1%WIKIPATHWAYS_20250310%WP5187%HOMO SAPIENS	10	10		
RETINOL METABOLISM%WIKIPATHWAYS_20250310%WP5188%HOMO SAPIENS	17	10		
COPPER METABOLISM%WIKIPATHWAYS_20250310%WP5189%HOMO SAPIENS	4		Rejected!	
CREATINE PATHWAY%WIKIPATHWAYS_20250310%WP5190%HOMO SAPIENS	5	5		
RESOLVIN E1 AND RESOLVIN D1 SIGNALING DECREASE INFLAMMATION%WIKIPATHWAYS_20250310%WP5191%HOMO SAPIENS	12	10		
MODULATION OF PI3K AKT MTOR SIGNALING BY BIOACTIVE SPHINGOLIPIDS%WIKIPATHWAYS_20250310%WP5192%HOMO SAPIENS	14	13		
CHOLESTEROL SYNTHESIS DISORDERS%WIKIPATHWAYS_20250310%WP5193%HOMO SAPIENS	18	18		
SYNTHESIS OF CERAMIDES AND 1 DEOXYCERAMIDES%WIKIPATHWAYS_20250310%WP5194%HOMO SAPIENS	22	19		
DISORDERS IN KETOLYSIS%WIKIPATHWAYS_20250310%WP5195%HOMO SAPIENS	5	5		
INFLAMMATORY BOWEL DISEASE SIGNALING%WIKIPATHWAYS_20250310%WP5198%HOMO SAPIENS	43	30		
PTDINS 4 5 P2 IN CYTOKINESIS PATHWAY%WIKIPATHWAYS_20250310%WP5199%HOMO SAPIENS	12	11		
DRAVET SYNDROME%WIKIPATHWAYS_20250310%WP5200%HOMO SAPIENS	29	26		
ALSTROM SYNDROME%WIKIPATHWAYS_20250310%WP5202%HOMO SAPIENS	34	32		
CLOCK CONTROLLED AUTOPHAGY IN BONE METABOLISM%WIKIPATHWAYS_20250310%WP5205%HOMO SAPIENS	80	70		
AMINO ACID CONJUGATION OF BENZOIC ACID%WIKIPATHWAYS_20250310%WP521%HOMO SAPIENS	4		Rejected!	
GLUCOSE METABOLISM IN TRIPLE NEGATIVE BREAST CANCER CELLS%WIKIPATHWAYS_20250310%WP5211%HOMO SAPIENS	8	8		
AMINO ACID METABOLISM IN TRIPLE NEGATIVE BREAST CANCER CELLS%WIKIPATHWAYS_20250310%WP5213%HOMO SAPIENS	7	6		
TARGETED AGENTS IN TRIPLE NEGATIVE BREAST CANCER%WIKIPATHWAYS_20250310%WP5215%HOMO SAPIENS	38	38		
WARBURG EFFECT MODULATED BY DEUBIQUITINATING ENZYMES AND THEIR SUBSTRATES%WIKIPATHWAYS_20250310%WP5216%HOMO SAPIENS	26	26		
EXTRAFOLLICULAR AND FOLLICULAR B CELL ACTIVATION BY SARS COV 2%WIKIPATHWAYS_20250310%WP5218%HOMO SAPIENS	76	62		
DIET DEPENDENT TRIMETHYLAMINE TRIMETHYLAMINE N OXIDE METABOLISM %WIKIPATHWAYS_20250310%WP5219%HOMO SAPIENS	4		Rejected!	
METABOLIC REPROGRAMMING IN PANCREATIC CANCER%WIKIPATHWAYS_20250310%WP5220%HOMO SAPIENS	42	42		
2Q11 2 COPY NUMBER VARIATION SYNDROME%WIKIPATHWAYS_20250310%WP5221%HOMO SAPIENS	33	28		
2Q13 COPY NUMBER VARIATION SYNDROME%WIKIPATHWAYS_20250310%WP5222%HOMO SAPIENS	63	47		
2Q21 1 COPY NUMBER VARIATION SYNDROME%WIKIPATHWAYS_20250310%WP5223%HOMO SAPIENS	18	10		
2Q37 COPY NUMBER VARIATION SYNDROME%WIKIPATHWAYS_20250310%WP5224%HOMO SAPIENS	143	113		
NEPHROTOXCICITY ADVERSE OUTCOME PATHWAY%WIKIPATHWAYS_20250310%WP5229%HOMO SAPIENS	2		Rejected!	
HIPPOCAMPAL SYNAPTOGENESIS AND NEUROGENESIS%WIKIPATHWAYS_20250310%WP5231%HOMO SAPIENS	24	21		
ARSENIC METABOLISM AND REACTIVE OXYGEN SPECIES GENERATION%WIKIPATHWAYS_20250310%WP5233%HOMO SAPIENS	10	10		
BARDET BIEDL SYNDROME%WIKIPATHWAYS_20250310%WP5234%HOMO SAPIENS	88	84		
ESTRADIOL REGULATION IN PORTO SINUSOIDAL VASCULAR DISEASE%WIKIPATHWAYS_20250310%WP5235%HOMO SAPIENS	5	5		
MARKERS OF KIDNEY CELL LINEAGE%WIKIPATHWAYS_20250310%WP5236%HOMO SAPIENS	58	50		
CHOLESTASIS%WIKIPATHWAYS_20250310%WP5238%HOMO SAPIENS	19	16		
LAC PHE PATHWAY%WIKIPATHWAYS_20250310%WP5239%HOMO SAPIENS	2		Rejected!	
G13 SIGNALING%WIKIPATHWAYS_20250310%WP524%HOMO SAPIENS	38	36		
MITOCHONDRIAL BETA OXIDATION%WIKIPATHWAYS_20250310%WP5241%HOMO SAPIENS	9	9		
COVID 19 AND ENDOTHELIAL CELL SENESCENCE%WIKIPATHWAYS_20250310%WP5256%HOMO SAPIENS	5		Rejected!	
ROS IN COVID 19 ENDOTHELIAL DYSFUNCTION%WIKIPATHWAYS_20250310%WP5258%HOMO SAPIENS	8	6		
NEUROGENESIS REGULATION IN THE OLFACTORY EPITHELIUM%WIKIPATHWAYS_20250310%WP5265%HOMO SAPIENS	57	51		
GENETIC CAUSES OF PORTO SINUSOIDAL VASCULAR DISEASE%WIKIPATHWAYS_20250310%WP5269%HOMO SAPIENS	37	36		
LDL INFLUENCE ON CD14 AND TLR4%WIKIPATHWAYS_20250310%WP5272%HOMO SAPIENS	23	21		
EFFECT OF INTESTINAL MICROBIOME ON ANTICOAGULANT RESPONSE OF VITAMIN K ANTAGONISTS%WIKIPATHWAYS_20250310%WP5273%HOMO SAPIENS	8	7		
ETHER LIPID BIOSYNTHESIS%WIKIPATHWAYS_20250310%WP5275%HOMO SAPIENS	20	20		
ESTROGEN METABOLISM%WIKIPATHWAYS_20250310%WP5276%HOMO SAPIENS	24	20		
STEROID HORMONE PRECURSOR BIOSYNTHESIS%WIKIPATHWAYS_20250310%WP5277%HOMO SAPIENS	9	6		
MINERALOCORTICOID BIOSYNTHESIS%WIKIPATHWAYS_20250310%WP5279%HOMO SAPIENS	14	10		
ACETYLCHOLINE SYNTHESIS%WIKIPATHWAYS_20250310%WP528%HOMO SAPIENS	7	5		
GLUCOCORTICOID BIOSYNTHESIS%WIKIPATHWAYS_20250310%WP5280%HOMO SAPIENS	14	10		
CHRONIC HYPERGLYCEMIA IMPAIRMENT OF NEURON FUNCTION%WIKIPATHWAYS_20250310%WP5283%HOMO SAPIENS	46	33		
CELL INTERACTIONS IN PANCREATIC CANCER MICROENVIRONMENT%WIKIPATHWAYS_20250310%WP5284%HOMO SAPIENS	27	25		
IMMUNE INFILTRATION IN PANCREATIC CANCER%WIKIPATHWAYS_20250310%WP5285%HOMO SAPIENS	39	21		
17Q12 COPY NUMBER VARIATION SYNDROME%WIKIPATHWAYS_20250310%WP5287%HOMO SAPIENS	101	77		
AXON GUIDANCE%WIKIPATHWAYS_20250310%WP5289%HOMO SAPIENS	72	67		
GLYCOSPHINGOLIPID METABOLISM%WIKIPATHWAYS_20250310%WP5292%HOMO SAPIENS	21	19		
ACUTE MYELOID LEUKEMIA%WIKIPATHWAYS_20250310%WP5293%HOMO SAPIENS	69	63		
SILDENAFIL TREATMENT%WIKIPATHWAYS_20250310%WP5294%HOMO SAPIENS	23	23		
GANGLIO SERIES SPHINGOLIPID METABOLISM%WIKIPATHWAYS_20250310%WP5299%HOMO SAPIENS	13	13		
ID SIGNALING%WIKIPATHWAYS_20250310%WP53%HOMO SAPIENS	16	15		
CYTOKINES AND INFLAMMATORY RESPONSE%WIKIPATHWAYS_20250310%WP530%HOMO SAPIENS	26	13		
TROP2 REGULATORY SIGNALING%WIKIPATHWAYS_20250310%WP5300%HOMO SAPIENS	45	43		
NEOLACTO SERIES SPHINGOLIPID METABOLISM%WIKIPATHWAYS_20250310%WP5302%HOMO SAPIENS	11	10		
LACTO SERIES SPHINGOLIPID METABOLISM%WIKIPATHWAYS_20250310%WP5303%HOMO SAPIENS	6	5		
CHOLESTEROL METABOLISM%WIKIPATHWAYS_20250310%WP5304%HOMO SAPIENS	72	61		
DNA MISMATCH REPAIR%WIKIPATHWAYS_20250310%WP531%HOMO SAPIENS	23	22		
ISOGLOBO SERIES SPHINGOLIPIDS%WIKIPATHWAYS_20250310%WP5311%HOMO SAPIENS	1		Rejected!	
METABOLIC PATHWAYS OF FIBROBLASTS%WIKIPATHWAYS_20250310%WP5312%HOMO SAPIENS	32	31		
CARNOSINE METABOLISM OF GLIAL CELLS%WIKIPATHWAYS_20250310%WP5313%HOMO SAPIENS	4		Rejected!	
LACTATE SHUTTLE IN GLIAL CELLS%WIKIPATHWAYS_20250310%WP5314%HOMO SAPIENS	13	13		
SEBALEIC ACID FORMATION AND METABOLISM%WIKIPATHWAYS_20250310%WP5315%HOMO SAPIENS	5	5		
PRIMARY OVARIAN INSUFFICIENCY%WIKIPATHWAYS_20250310%WP5316%HOMO SAPIENS	174	131		
FEMALE STEROID HORMONES IN CARDIOMYOCYTE ENERGY METABOLISM%WIKIPATHWAYS_20250310%WP5318%HOMO SAPIENS	14	13		
MALE STEROID HORMONES IN CARDIOMYOCYTE ENERGY METABOLISM%WIKIPATHWAYS_20250310%WP5320%HOMO SAPIENS	13	10		
PROSTAGLANDIN AND LEUKOTRIENE METABOLISM IN SENESCENCE %WIKIPATHWAYS_20250310%WP5321%HOMO SAPIENS	34	32		
FATTY ACID AND LIPOPROTEIN TRANSPORT IN HEPATOCYTES%WIKIPATHWAYS_20250310%WP5323%HOMO SAPIENS	35	30		
OCTADECANOID FORMATION FROM LINOLEIC ACID%WIKIPATHWAYS_20250310%WP5324%HOMO SAPIENS	13	8		
CHOLESTEROL BIOSYNTHESIS PATHWAY IN HEPATOCYTES%WIKIPATHWAYS_20250310%WP5329%HOMO SAPIENS	43	40		
AUTOPHAGY IN PANCREATIC DUCTAL ADENOCARCINOMA%WIKIPATHWAYS_20250310%WP5331%HOMO SAPIENS	20	20		
ENTEROCYTE CHOLESTEROL METABOLISM%WIKIPATHWAYS_20250310%WP5333%HOMO SAPIENS	36	31		
INDUCTION OF AUTOPHAGY AND TOLL LIKE RECEPTOR SIGNALING BY GRAPHENE OXIDE %WIKIPATHWAYS_20250310%WP5336%HOMO SAPIENS	11	9		
GLYCOLYSIS AND GLUCONEOGENESIS%WIKIPATHWAYS_20250310%WP534%HOMO SAPIENS	45	41		
PATHOPHYSIOLOGICAL ROLES OF DUX4 IN FSHD1%WIKIPATHWAYS_20250310%WP5342%HOMO SAPIENS	36	11		
ABNORMAL CALCIUM HANDLING AND ITS EFFECTS ON MUSCLE CONTRACTION IN DMD%WIKIPATHWAYS_20250310%WP5343%HOMO SAPIENS	14	10		
CARDIOMYOCYTE SIGNALING CONVERGING ON TITIN%WIKIPATHWAYS_20250310%WP5344%HOMO SAPIENS	33	29		
1P36 COPY NUMBER VARIATION SYNDROME%WIKIPATHWAYS_20250310%WP5345%HOMO SAPIENS	103	91		
8P23 1 COPY NUMBER VARIATION SYNDROME%WIKIPATHWAYS_20250310%WP5346%HOMO SAPIENS	55	39		
IL26 SIGNALING%WIKIPATHWAYS_20250310%WP5347%HOMO SAPIENS	48	34		
11P11 2 COPY NUMBER VARIATION SYNDROME %WIKIPATHWAYS_20250310%WP5348%HOMO SAPIENS	56	51		
KLEEFSTRA SYNDROME%WIKIPATHWAYS_20250310%WP5351%HOMO SAPIENS	29	28		
10Q11 21Q11 23 COPY NUMBER VARIATION SYNDROME%WIKIPATHWAYS_20250310%WP5352%HOMO SAPIENS	61	51		
MACROPHAGE STIMULATING PROTEIN MSP SIGNALING%WIKIPATHWAYS_20250310%WP5353%HOMO SAPIENS	108	98		
METABOLIC EPILEPTIC DISORDERS%WIKIPATHWAYS_20250310%WP5355%HOMO SAPIENS	92	85		
AFFECTED PATHWAYS IN DUCHENNE MUSCULAR DYSTROPHY%WIKIPATHWAYS_20250310%WP5356%HOMO SAPIENS	75	60		
JAK STAT SIGNALING IN THE REGULATION OF BETA CELLS%WIKIPATHWAYS_20250310%WP5358%HOMO SAPIENS	34	30		
CALCIUM REGULATION IN CARDIAC CELLS%WIKIPATHWAYS_20250310%WP536%HOMO SAPIENS	152	127		
KCNQ2 RELATED EPILEPSIES%WIKIPATHWAYS_20250310%WP5360%HOMO SAPIENS	19	17		
TAR SYNDROME%WIKIPATHWAYS_20250310%WP5362%HOMO SAPIENS	63	60		
4P16 3 COPY NUMBER VARIATION%WIKIPATHWAYS_20250310%WP5365%HOMO SAPIENS	32	30		
NF1 COPY NUMBER VARIATION SYNDROME %WIKIPATHWAYS_20250310%WP5366%HOMO SAPIENS	109	75		
RUBINSTEIN TAYBI SYNDROME 1%WIKIPATHWAYS_20250310%WP5367%HOMO SAPIENS	15	15		
SULFATASE AND AROMATASE PATHWAY%WIKIPATHWAYS_20250310%WP5368%HOMO SAPIENS	14	9		
INVOLVEMENT OF SECRETASE IN NEURODEGENERATIVE DISEASES%WIKIPATHWAYS_20250310%WP5372%HOMO SAPIENS	17	17		
OSTEOARTHRITIC CHONDROCYTE HYPERTROPHY%WIKIPATHWAYS_20250310%WP5373%HOMO SAPIENS	50	45		
17P13 3 YWHAE COPY NUMBER VARIATION%WIKIPATHWAYS_20250310%WP5376%HOMO SAPIENS	21	20		
5Q35 COPY NUMBER VARIATION%WIKIPATHWAYS_20250310%WP5380%HOMO SAPIENS	111	100		
SMITH MAGENIS AND POTOCKI LUPSKI SYNDROME COPY NUMBER VARIATION%WIKIPATHWAYS_20250310%WP5381%HOMO SAPIENS	159	144		
TGFB SMAD SIGNALING%WIKIPATHWAYS_20250310%WP5382%HOMO SAPIENS	12	12		
GROWTH FACTORS AND HORMONES IN BETA CELL PROLIFERATION%WIKIPATHWAYS_20250310%WP5385%HOMO SAPIENS	26	23		
PANCREATIC CANCER SUBTYPES%WIKIPATHWAYS_20250310%WP5390%HOMO SAPIENS	50	16		
UDP DERIVED SUGARS SYNTHESIS IN FIBROBLASTS%WIKIPATHWAYS_20250310%WP5394%HOMO SAPIENS	11	10		
GLYCOSAMINOGLYCAN SYNTHESIS IN FIBROBLASTS%WIKIPATHWAYS_20250310%WP5395%HOMO SAPIENS	41	37		
ENTEROHEPATIC CIRCULATION OF BILE ACIDS%WIKIPATHWAYS_20250310%WP5396%HOMO SAPIENS	12	7		
VITAMIN A1 AND A5 X PATHWAYS%WIKIPATHWAYS_20250310%WP5397%HOMO SAPIENS	6	5		
NRXN1 DELETION SYNDROME%WIKIPATHWAYS_20250310%WP5398%HOMO SAPIENS	17	9		
NPHP1 DELETION SYNDROME%WIKIPATHWAYS_20250310%WP5399%HOMO SAPIENS	11	11		
6Q16 COPY NUMBER VARIATION%WIKIPATHWAYS_20250310%WP5400%HOMO SAPIENS	14	8		
7Q11 23 DISTAL COPY NUMBER VARIATION%WIKIPATHWAYS_20250310%WP5401%HOMO SAPIENS	22	19		
10Q22Q23 COPY NUMBER VARIATION%WIKIPATHWAYS_20250310%WP5402%HOMO SAPIENS	64	47		
13Q12 OR CRYL1 COPY NUMBER VARIATION %WIKIPATHWAYS_20250310%WP5405%HOMO SAPIENS	1		Rejected!	
13Q12 12 COPY NUMBER VARIATION%WIKIPATHWAYS_20250310%WP5406%HOMO SAPIENS	34	27		
15Q11Q13 COPY NUMBER VARIATION%WIKIPATHWAYS_20250310%WP5407%HOMO SAPIENS	59	57		
15Q25 COPY NUMBER VARIATION%WIKIPATHWAYS_20250310%WP5408%HOMO SAPIENS	46	41		
PAFAH1B1 COPY NUMBER VARIATION%WIKIPATHWAYS_20250310%WP5409%HOMO SAPIENS	11	10		
PHOSPHATIDYL INOSITOL PHOSPHATE PATHWAY%WIKIPATHWAYS_20250310%WP5411%HOMO SAPIENS	46	44		
8Q11 23 RB1CC1 COPY NUMBER VARIATION%WIKIPATHWAYS_20250310%WP5412%HOMO SAPIENS	16	16		
IDO METABOLIC PATHWAY%WIKIPATHWAYS_20250310%WP5414%HOMO SAPIENS	11	10		
CELL LINEAGE MAP FOR NEURONAL DIFFERENTIATION%WIKIPATHWAYS_20250310%WP5417%HOMO SAPIENS	132	83		
ADHD AND AUTISM ASD PATHWAYS%WIKIPATHWAYS_20250310%WP5420%HOMO SAPIENS	371	284		
IL19 SIGNALING%WIKIPATHWAYS_20250310%WP5422%HOMO SAPIENS	28	22		
OMEGA 6 FATTY ACIDS IN SENESCENCE%WIKIPATHWAYS_20250310%WP5424%HOMO SAPIENS	48	43		
HDAC6 INTERACTIONS IN THE CENTRAL NERVOUS SYSTEM%WIKIPATHWAYS_20250310%WP5426%HOMO SAPIENS	112	107		
FGFR4 P G388R SIGNALING%WIKIPATHWAYS_20250310%WP5428%HOMO SAPIENS	3		Rejected!	
FLT3 P GLN640SERFSTER8 SIGNALING%WIKIPATHWAYS_20250310%WP5431%HOMO SAPIENS	4		Rejected!	
OMEGA 3 FATTY ACIDS IN SENESCENCE%WIKIPATHWAYS_20250310%WP5432%HOMO SAPIENS	31	25		
PGK1 PKM2 KHKC KHKA ACTING AS PROTEIN KINASES%WIKIPATHWAYS_20250310%WP5433%HOMO SAPIENS	15	14		
CANCER PATHWAYS%WIKIPATHWAYS_20250310%WP5434%HOMO SAPIENS	509	449		
GNAQ PATHWAYS IN PORT WINE STAIN%WIKIPATHWAYS_20250310%WP5437%HOMO SAPIENS	21	21		
EPAC1 AND PKA REDUCTION OF RETINAL INFLAMMATION%WIKIPATHWAYS_20250310%WP5440%HOMO SAPIENS	8	8		
ARTEMISININ INHIBITION OF UVEAL MELANOMA%WIKIPATHWAYS_20250310%WP5441%HOMO SAPIENS	4		Rejected!	
WNT BETA CATENIN SIGNALING INHIBITORS IN CURRENT AND PAST CLINICAL TRIALS%WIKIPATHWAYS_20250310%WP5442%HOMO SAPIENS	5	5		
EFFECTS OF MFN2 MUTATION%WIKIPATHWAYS_20250310%WP5443%HOMO SAPIENS	24	24		
ACETAMINOPHEN IN ANALGESIA AND ANTIPYRESIS%WIKIPATHWAYS_20250310%WP5444%HOMO SAPIENS	9	7		
HUNGER AND SATIETY%WIKIPATHWAYS_20250310%WP5445%HOMO SAPIENS	8		Rejected!	
GLP 1 SECRETION FROM INTESTINE TO PORTAL VEIN%WIKIPATHWAYS_20250310%WP5446%HOMO SAPIENS	5		Rejected!	
GLP 1 IN PANCREATIC ISLET CELLS%WIKIPATHWAYS_20250310%WP5447%HOMO SAPIENS	7		Rejected!	
COMPLEMENT ACTIVATION%WIKIPATHWAYS_20250310%WP545%HOMO SAPIENS	23	19		
GLP 1 FROM INTESTINE AND PANCREAS AND ROLE IN GLUCOSE HOMEOSTASIS%WIKIPATHWAYS_20250310%WP5452%HOMO SAPIENS	6		Rejected!	
PRIMARY OVARIAN INSUFFICIENCY%WIKIPATHWAYS_20250310%WP5461%HOMO SAPIENS	137	108		
FANCONI ANEMIA%WIKIPATHWAYS_20250310%WP5465%HOMO SAPIENS	48	47		
HALLMARK OF CANCER METASTASIS AND EPITHELIAL TO MESENCHYMAL TRANSITION%WIKIPATHWAYS_20250310%WP5469%HOMO SAPIENS	23	20		
EFFECT OF OMEGA 3 PUFA ON HUNTINGTON 39 S DISEASE PATHWAYS%WIKIPATHWAYS_20250310%WP5470%HOMO SAPIENS	120	105		
PHOSPHOINOSITIDE 3 KINASE PI3K FAMILY%WIKIPATHWAYS_20250310%WP5472%HOMO SAPIENS	13	13		
CYTOKINE CYTOKINE RECEPTOR INTERACTION%WIKIPATHWAYS_20250310%WP5473%HOMO SAPIENS	255	165		
CATABOLISM OF SKELETAL MUSCLE IN CACHEXIA%WIKIPATHWAYS_20250310%WP5474%HOMO SAPIENS	40	38		
HALLMARK OF CANCER SUSTAINING PROLIFERATIVE SIGNALING%WIKIPATHWAYS_20250310%WP5475%HOMO SAPIENS	98	95		
MOLECULAR PATHWAY FOR OXIDATIVE STRESS%WIKIPATHWAYS_20250310%WP5477%HOMO SAPIENS	49	44		
HALLMARK OF CANCER NON MUTATIONAL EPIGENETIC REPROGRAMMING%WIKIPATHWAYS_20250310%WP5483%HOMO SAPIENS	17	17		
POST COVID NEUROINFLAMMATION%WIKIPATHWAYS_20250310%WP5485%HOMO SAPIENS	24	15		
PATHWAYS INTO METHIONINE AND FOLATE CYCLES%WIKIPATHWAYS_20250310%WP5488%HOMO SAPIENS	45	41		
REGULATION OF CYTOTOXIC T CELL RESPONSES BY MALAT1 MIR 15 16 CIRCUIT %WIKIPATHWAYS_20250310%WP5489%HOMO SAPIENS	12	10		
INHIBITION OF GNAQ REGULATED SIGNALING IN UVEAL MELANOMA%WIKIPATHWAYS_20250310%WP5490%HOMO SAPIENS	33	33		
TRANSCRIPTIONAL REGULATION OF MEMORY B CELL DIFFERENTIATION%WIKIPATHWAYS_20250310%WP5491%HOMO SAPIENS	48	45		
AMPK REGULATION OF MAMMARY MILK PROTEIN SYNTHESIS%WIKIPATHWAYS_20250310%WP5492%HOMO SAPIENS	20	17		
EFFECT OF DASATINIB ON THE BCR ABL SIGNALING PATHWAY%WIKIPATHWAYS_20250310%WP5493%HOMO SAPIENS	45	44		
TYROSINE KINASE INHIBITORS IN GLIOBLASTOMA%WIKIPATHWAYS_20250310%WP5494%HOMO SAPIENS	26	25		
TARGETING YAP IN PANCREATIC DUCTAL ADENOCARCINOMA PDAC %WIKIPATHWAYS_20250310%WP5495%HOMO SAPIENS	26	25		
TARGETED THERAPY IN BREAST CANCER%WIKIPATHWAYS_20250310%WP5496%HOMO SAPIENS	26	26		
CYCLIN DEPENDENT KINASE 4 6 INHIBITORS IN BREAST CANCER%WIKIPATHWAYS_20250310%WP5497%HOMO SAPIENS	38	36		
BIOGENIC AMINE SYNTHESIS%WIKIPATHWAYS_20250310%WP550%HOMO SAPIENS	15	10		
BEMPEDOIC ACID THERAPY IN ATHEROSCLEROSIS AND METABOLIC SYNDROME%WIKIPATHWAYS_20250310%WP5500%HOMO SAPIENS	26	24		
GNAQ P R183Q DRIVES CAPILLARY MALFORMATION%WIKIPATHWAYS_20250310%WP5501%HOMO SAPIENS	25	23		
16P13 11 COPY NUMBER VARIATION SYNDROME %WIKIPATHWAYS_20250310%WP5502%HOMO SAPIENS	29	29		
ALBUTEROL AND BUDESONIDE THERAPY FOR ASTHMA%WIKIPATHWAYS_20250310%WP5503%HOMO SAPIENS	26	22		
DISORDERS OF MITOCHONDRIAL HOMEOSTATIS DYNAMICS PROTEIN IMPORT AND QUALITY CONTROL%WIKIPATHWAYS_20250310%WP5504%HOMO SAPIENS	63	61		
GLYCOSYLPHOSPHATIDYL INOSITOL ANCHOR PATHWAY%WIKIPATHWAYS_20250310%WP5505%HOMO SAPIENS	26	26		
DISORDERS OF NAD METABOLISM%WIKIPATHWAYS_20250310%WP5506%HOMO SAPIENS	5	5		
MITOCHONDRIAL CARRIER DEFICIENCY ASSOCIATED WITH SHUTTLE DISTURBANCES%WIKIPATHWAYS_20250310%WP5507%HOMO SAPIENS	5	5		
GIP AND GLP 1 FUNCTION BY TISSUE%WIKIPATHWAYS_20250310%WP5509%HOMO SAPIENS	2		Rejected!	
VEDOLIZUMAB THERAPY FOR INFLAMMATORY BOWEL DISEASE%WIKIPATHWAYS_20250310%WP5512%HOMO SAPIENS	10	9		
DNAJB1 PRKACA FUSION IN FIBROLAMELLAR LIVER CANCER%WIKIPATHWAYS_20250310%WP5514%HOMO SAPIENS	11	11		
IL23 INHIBITORS IN INFLAMMATORY BOWEL DISEASE%WIKIPATHWAYS_20250310%WP5516%HOMO SAPIENS	18	12		
ACE INHIBITOR PATHWAY%WIKIPATHWAYS_20250310%WP554%HOMO SAPIENS	17	13		
COMPLEMENT AND COAGULATION CASCADES%WIKIPATHWAYS_20250310%WP558%HOMO SAPIENS	58	52		
TGF BETA RECEPTOR SIGNALING%WIKIPATHWAYS_20250310%WP560%HOMO SAPIENS	55	50		
HEME BIOSYNTHESIS%WIKIPATHWAYS_20250310%WP561%HOMO SAPIENS	9	8		
MONOAMINE GPCRS%WIKIPATHWAYS_20250310%WP58%HOMO SAPIENS	33	11		
EPO RECEPTOR SIGNALING%WIKIPATHWAYS_20250310%WP581%HOMO SAPIENS	26	26		
INTERFERON TYPE I SIGNALING%WIKIPATHWAYS_20250310%WP585%HOMO SAPIENS	54	54		
NOTCH SIGNALING%WIKIPATHWAYS_20250310%WP61%HOMO SAPIENS	54	51		
TYPE II INTERFERON SIGNALING%WIKIPATHWAYS_20250310%WP619%HOMO SAPIENS	37	34		
OXIDATIVE PHOSPHORYLATION%WIKIPATHWAYS_20250310%WP623%HOMO SAPIENS	60	60		
GLUCOSE HOMEOSTASIS%WIKIPATHWAYS_20250310%WP661%HOMO SAPIENS	1		Rejected!	
ERBB SIGNALING%WIKIPATHWAYS_20250310%WP673%HOMO SAPIENS	90	85		
ARACHIDONATE EPOXYGENASE EPOXIDE HYDROLASE%WIKIPATHWAYS_20250310%WP678%HOMO SAPIENS	7	7		
CATALYTIC CYCLE OF MAMMALIAN FLAVIN CONTAINING MONOOXYGENASES FMOS %WIKIPATHWAYS_20250310%WP688%HOMO SAPIENS	5	5		
T CELL RECEPTOR SIGNALING%WIKIPATHWAYS_20250310%WP69%HOMO SAPIENS	75	75		
POLYOL PATHWAY%WIKIPATHWAYS_20250310%WP690%HOMO SAPIENS	4		Rejected!	
TAMOXIFEN METABOLISM%WIKIPATHWAYS_20250310%WP691%HOMO SAPIENS	21	14		
SULFATION BIOTRANSFORMATION REACTION%WIKIPATHWAYS_20250310%WP692%HOMO SAPIENS	18	11		
ARYLAMINE METABOLISM%WIKIPATHWAYS_20250310%WP694%HOMO SAPIENS	6	5		
BENZO A PYRENE METABOLISM%WIKIPATHWAYS_20250310%WP696%HOMO SAPIENS	9	7		
ESTROGEN METABOLISM%WIKIPATHWAYS_20250310%WP697%HOMO SAPIENS	18	15		
GLUCURONIDATION%WIKIPATHWAYS_20250310%WP698%HOMO SAPIENS	26	22		
AFLATOXIN B1 METABOLISM%WIKIPATHWAYS_20250310%WP699%HOMO SAPIENS	7	5		
METAPATHWAY BIOTRANSFORMATION PHASE I AND II%WIKIPATHWAYS_20250310%WP702%HOMO SAPIENS	184	137		
METHYLATION PATHWAYS%WIKIPATHWAYS_20250310%WP704%HOMO SAPIENS	9	8		
SUDDEN INFANT DEATH SYNDROME SIDS SUSCEPTIBILITY PATHWAYS%WIKIPATHWAYS_20250310%WP706%HOMO SAPIENS	160	120		
DNA DAMAGE RESPONSE%WIKIPATHWAYS_20250310%WP707%HOMO SAPIENS	69	65		
DNA DAMAGE RESPONSE ONLY ATM DEPENDENT %WIKIPATHWAYS_20250310%WP710%HOMO SAPIENS	110	103		
ESTROGEN SIGNALING%WIKIPATHWAYS_20250310%WP712%HOMO SAPIENS	23	22		
VITAMIN A AND CAROTENOID METABOLISM%WIKIPATHWAYS_20250310%WP716%HOMO SAPIENS	43	32		
SEROTONIN HTR1 GROUP AND FOS PATHWAY%WIKIPATHWAYS_20250310%WP722%HOMO SAPIENS	37	31		
MONOAMINE TRANSPORT%WIKIPATHWAYS_20250310%WP727%HOMO SAPIENS	32	25		
SEROTONIN RECEPTOR 2 AND ELK SRF GATA4 SIGNALING%WIKIPATHWAYS_20250310%WP732%HOMO SAPIENS	20	17		
SEROTONIN RECEPTOR 4 6 7 AND NR3C SIGNALING%WIKIPATHWAYS_20250310%WP734%HOMO SAPIENS	19	16		
TOLL LIKE RECEPTOR SIGNALING%WIKIPATHWAYS_20250310%WP75%HOMO SAPIENS	95	77		
TCA CYCLE AKA KREBS OR CITRIC ACID CYCLE %WIKIPATHWAYS_20250310%WP78%HOMO SAPIENS	18	18		
NUCLEOTIDE GPCRS%WIKIPATHWAYS_20250310%WP80%HOMO SAPIENS	11	9		
PROSTAGLANDIN SYNTHESIS AND REGULATION%WIKIPATHWAYS_20250310%WP98%HOMO SAPIENS	45	42		
